Processing 00000000.tx.1: Meta-Analysis of Nonsteroidal Antiinflammatory Drug Use and Risk of Dementia Anton J. 

Phrase: "Meta-Analysis of Nonsteroidal Antiinflammatory Drug Use"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0282458:Meta-Analysis [Intellectual Product]
   778   C0920317:Meta-Analysis [Research Activity]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1042496:Meta [Eukaryote]
   748   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "Risk of Dementia Anton J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.2: M. de Craen, Jacobijn Gussekloo, Bram Vrijsen and Rudi G. 

Phrase: "M. de Craen,"

Phrase: "Jacobijn Gussekloo,"

Phrase: "Bram Vrijsen"

Phrase: "and"

Phrase: "Rudi G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.3: J. 

Phrase: "J."
Processing 00000000.tx.4: Westendorp From the Section of Gerontology and Geriatrics, Department of General Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands. 

Phrase: "Westendorp From the Section of Gerontology"

Phrase: "and"

Phrase: "Geriatrics,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017469:Geriatrics [Biomedical Occupation or Discipline]
  1000   C1552300:Geriatrics [Professional or Occupational Group]
   966 E C1704440:Geriatric [Qualitative Concept]
   966 E C1999167:geriatric [Population Group]

Phrase: "Department of General Internal Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "Leiden University Medical Center,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   861   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   861   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   812   C0041740:University [Manufactured Object,Organization]
   812   C0205099:Center [Spatial Concept]
   812   C0205476:Medical [Functional Concept]

Phrase: "Leiden,"

Phrase: "the Netherlands."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027778:The Netherlands [Geographic Area]
           Netherlands
Processing 00000000.tx.5: Received for publication March 23, 2004; 

Phrase: "Received for publication March 23,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C0450348:23 [Quantitative Concept]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "2004"

Phrase: ";"
Processing 00000000.tx.6: accepted for publication August 11, 2004.  

Phrase: "accepted for publication August 11,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1272684:Accepted [Qualitative Concept]
   760   C1548435:Accepted [Idea or Concept]
   760   C1704324:Publication [Intellectual Product]
   726 E C1548601:Accept [Idea or Concept]

Phrase: "2004."
Processing 00000000.tx.7: ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  The authors performed a systematic review to summarize the epidemiologic evidence on the association between use of nonsteroidal antiinflammatory drugs (NSAIDs) and the risk of dementia. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "a systematic review to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1955832:Review, Systematic [Intellectual Product]
   827   C0220922:systematic [Functional Concept]
   827   C0282443:Review [Intellectual Product]
   827   C1552617:Review [Idea or Concept]

Phrase: "summarize"

Phrase: "the epidemiologic evidence on the association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332120:Evidence [Functional Concept]

Phrase: "between use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of nonsteroidal antiinflammatory drugs (NSAIDs)"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0003211:Nonsteroidal Anti-inflammatory Drugs [Pharmacologic Substance]
   988 E C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   901   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   827   C0013227:Drugs [Pharmacologic Substance]
   827   C1515999:Anti-inflammatory [Qualitative Concept]
   793 E C1254351:Drug [Pharmacologic Substance]
   755 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   755 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   727 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "and"

Phrase: "the risk of dementia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.8: A total of 25 case-control and cohort studies that reported an odds ratio/relative risk were included. 

Phrase: "A total of 25 case-control"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "cohort studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0009247:Cohort Studies [Quantitative Concept]
   861   C0599755:Cohort [Population Group]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "that"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "an odds ratio/relative risk"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0242492:Relative Risk [Quantitative Concept]
   812   C0035647:Risk [Qualitative Concept]
   812   C0080103:Relative [Family Group]
   812   C0205345:Relative [Qualitative Concept]
   812   C1547039:*Relative [Quantitative Concept]

Phrase: "were"

Phrase: "included."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]
Processing 00000000.tx.9: Study-specific log relative risks were weighted by the inverse of their variances to obtain pooled relative risks and 95% confidence intervals. 

Phrase: "Study-specific log relative risks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0242492:Risks, Relative [Quantitative Concept]
   804   C0035647:Risks [Qualitative Concept]
   804   C0080103:Relative [Family Group]
   804   C0205345:Relative [Qualitative Concept]
   804   C1547039:*Relative [Quantitative Concept]

Phrase: "were"

Phrase: "weighted by the inverse of their variances to"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   744   C0005910:weighted [Organism Attribute]
   744   C0043100:weighted [Quantitative Concept]
   744   C0439850:Inverse [Qualitative Concept]
   744   C1305866:weighted [Diagnostic Procedure]
   711 E C1705104:Weight [Idea or Concept]
   711   C1711260:Variance [Qualitative Concept]
   711   C2348152:Variance [Quantitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "pooled relative risks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0242492:Risks, Relative [Quantitative Concept]
   827   C0035647:Risks [Qualitative Concept]
   827   C0080103:Relative [Family Group]
   827   C0205345:Relative [Qualitative Concept]
   827   C1547039:*Relative [Quantitative Concept]

Phrase: "and"

Phrase: "95% confidence intervals."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   901   C0009667:Confidence Intervals [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:intervals [Temporal Concept]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   793 E C1552654:Interval [Idea or Concept]
   793 E C1552713:Interval [Intellectual Product]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]
Processing 00000000.tx.10: The authors divided the reports into studies with prevalent dementia cases, studies with incident dementia cases, and studies where cognitive decline was used as the clinical endpoint. 

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "divided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332849:Divided [Functional Concept]

Phrase: "the reports into studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   819   C1317750:reports studies [Intellectual Product]
   786 E C1831145:Study report [Clinical Attribute]
   770   C0684224:Reports [Intellectual Product]
   770   C0700287:reports [Health Care Activity]
   737 E C3273238:Report [Intellectual Product]

Phrase: "with prevalent dementia cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "studies with incident dementia cases,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   781   C0085973:Case Studies [Intellectual Product]
   760   C0011265:dementia [Mental or Behavioral Dysfunction]
   760   C0497327:Dementia [Mental or Behavioral Dysfunction]
   760   C0557651:Study [Manufactured Object]
   760   C0868928:Cases [Functional Concept]
   760   C0947630:studies [Laboratory Procedure]
   760   C1533148:Cases [Quantitative Concept]
   760   C1551358:incident [Idea or Concept]
   760   C2603343:Study [Research Activity]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "studies where cognitive decline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]

Phrase: "was"

Phrase: "used as the clinical endpoint."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   806   C2347784:Clinical Endpoint [Clinical Attribute]
   760   C0205210:Clinical [Qualitative Concept]
   760   C1273517:used [Finding]
   760   C2349179:End Point [Qualitative Concept]
   760   C2826544:ENDPOINT [Quantitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.11: The pooled relative risks of the three groups of studies were 0.51 (95% confidence interval (CI): 0.37, 0.70), 0.79 (95% CI: 0.68, 0.92), and 1.23 (95% CI: 0.70, 2.31), respectively. 

Phrase: "The pooled relative risks of the three groups of studies"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0242492:Risks, Relative [Quantitative Concept]
   739   C0035647:Risks [Qualitative Concept]
   739   C0080103:Relative [Family Group]
   739   C0205345:Relative [Qualitative Concept]
   739   C1547039:*Relative [Quantitative Concept]

Phrase: "were"

Phrase: "0.51"

Phrase: "(95% confidence interval (CI)"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.37,"

Phrase: "0.70"

Phrase: ")"

Phrase: ","

Phrase: "0.79"

Phrase: "(95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.68,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450387:68 [Intellectual Product]

Phrase: "0.92"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "1.23"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0450348:23 [Quantitative Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.70,"

Phrase: "2.31"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0450355:31 [Intellectual Product]
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.12: Within these subgroups, heterogeneity was present only in the studies with prevalent cases (p = 0.001). 

Phrase: "Within these subgroups,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1079230:subgroups [Virus]
   966 E C1515021:Subgroup [Classification]

Phrase: "heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019409:Heterogeneity [Qualitative Concept]
   916 E C1512426:Heterogenous [Idea or Concept]

Phrase: "was"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "only in the studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0205171:Only [Quantitative Concept]
   770   C0947630:studies [Laboratory Procedure]
   770   C1720467:Only [Intellectual Product]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "with prevalent cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "(p = 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.13: Because the benefit of NSAIDs in preventing dementia or cognitive impairment was 50% in studies with prevalent dementia cases, declined to 20% in studies with incident dementia cases, and was absent in studies where cognitive decline was used as the endpoint, the authors conclude that most of the reported beneficial effects of NSAIDs may result from various forms of bias: recall bias, prescription bias, and publication bias. 

Phrase: "Because"

Phrase: "the benefit of NSAIDs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0814225:Benefit [Quantitative Concept]

Phrase: "in preventing dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "or"

Phrase: "cognitive impairment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0338656:Cognitive impairment [Mental or Behavioral Dysfunction]
   861   C0684336:Impairment [Pathologic Function]

Phrase: "was"

Phrase: "50% in studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0947630:studies [Laboratory Procedure]
   756 E C0557651:Study [Manufactured Object]
   756 E C2603343:Study [Research Activity]

Phrase: "with prevalent dementia cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "declined to 20%"

Phrase: "in studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "with incident dementia cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "was"

Phrase: "absent in studies where cognitive decline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:Absent [Quantitative Concept]
   753   C2699517:ABSENT [Finding]

Phrase: "was"

Phrase: "used as the endpoint,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C1273517:used [Finding]
   770   C2349179:End Point [Qualitative Concept]
   770   C2826544:ENDPOINT [Quantitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "the authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that most of the reported beneficial effects of NSAIDs"
Meta Candidates (Total=20; Excluded=6; Pruned=0; Remaining=14)
   775   C0003211:Nonsteroidal Anti-inflammatory Drugs [Pharmacologic Substance]
   764 E C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   759   C0728866:effect of drugs [Functional Concept]
           drug effects
   756   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   748   C0683156:beneficial drug effect [Biologic Function]
   738   C0013227:Drugs [Pharmacologic Substance]
   738   C0684224:Reported [Intellectual Product]
   738   C0700287:Reported [Health Care Activity]
   738   C1280500:effects [Qualitative Concept]
   738   C1515999:Anti-inflammatory [Qualitative Concept]
           Anti-inflammatory effect
   738   C3496591:Reported [Clinical Attribute]
   737   C1516019:Antiinflammatory Effect [Physiologic Function]
   721 E C0728867:Drug effect [Pathologic Function]
   721 E C1411996:drug effect [Biologic Function]
   704 E C1254351:Drug [Pharmacologic Substance]
   704 E C2348382:Effect [Qualitative Concept]
   704 E C3273238:Report [Intellectual Product]

Phrase: "may"

Phrase: "result from various forms of bias"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   753   C0242568:Bias [Idea or Concept]
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   753   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   753   C1274040:Result [Functional Concept]
   753   C1504315:Bias [Bird]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]
   719 E C1061346:Bia [Eukaryote]
   719 E C1522492:Form [Functional Concept]
   719 E C1704746:BIA [Diagnostic Procedure]

Phrase: ":"

Phrase: "recall bias,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0242568:Bias [Idea or Concept]
   861   C1504315:Bias [Bird]
   827 E C1061346:Bia [Eukaryote]
   827 E C1704746:BIA [Diagnostic Procedure]

Phrase: "prescription bias,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0242568:Bias [Idea or Concept]
   861   C1504315:Bias [Bird]
   827 E C1061346:Bia [Eukaryote]
   827 E C1704746:BIA [Diagnostic Procedure]

Phrase: "and"

Phrase: "publication bias."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0206086:Publication Bias [Qualitative Concept]
   861   C0242568:Bias [Idea or Concept]
   861   C1504315:Bias [Bird]
   827 E C1061346:Bia [Eukaryote]
   827 E C1704746:BIA [Diagnostic Procedure]
Processing 00000000.tx.14: Alzheimer disease; 

Phrase: "Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.15: anti-inflammatory agents, non-steroidal; 

Phrase: "anti-inflammatory agents,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0003209:Anti-Inflammatory Agents [Pharmacologic Substance]
           Anti-inflammatory
   913   C0040616:anti-agents [Pharmacologic Substance]
   793   C0450442:Agent [Chemical Viewed Functionally]
   793   C1254351:Agent [Pharmacologic Substance]
   793   C1521826:Agent [Intellectual Product]
   734   C1515999:Anti-inflammatory [Qualitative Concept]

Phrase: "non-steroidal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1518422:Non [Functional Concept]
   789   C0038317:Steroid [Steroid]

Phrase: ";"
Processing 00000000.tx.16: dementia; 

Phrase: "dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: ";"
Processing 00000000.tx.17: meta-analysis Abbreviations: CI, confidence interval; 

Phrase: "meta-analysis Abbreviations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0000723:Abbreviations [Intellectual Product]
   734   C0282458:Meta-Analysis [Intellectual Product]
   734   C0920317:Meta-Analysis [Research Activity]

Phrase: ":"

Phrase: "CI,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0009667:Confidence Interval [Quantitative Concept]
   861   C0237529:Confidence [Mental Process]
   861   C1272706:Interval [Temporal Concept]
   861   C1552654:Interval [Idea or Concept]
   861   C1552713:Interval [Intellectual Product]
   861   C1704725:Confidence [Qualitative Concept]
   861   C1704726:Confidence [Mental Process]
   789 E C0558095:Confident [Individual Behavior]
   761 E C0009669:confidentiality [Idea or Concept]

Phrase: "confidence interval"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0009667:Confidence Interval [Quantitative Concept]
   861   C0237529:Confidence [Mental Process]
   861   C1272706:Interval [Temporal Concept]
   861   C1552654:Interval [Idea or Concept]
   861   C1552713:Interval [Intellectual Product]
   861   C1704725:Confidence [Qualitative Concept]
   861   C1704726:Confidence [Mental Process]
   789 E C0558095:Confident [Individual Behavior]
   761 E C0009669:confidentiality [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.18: NSAID(s), nonsteroidal antiinflammatory drug(s).  

Phrase: "NSAID"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
  1000   C0003211:Non-steroidal anti-inflammatory drug [Pharmacologic Substance]
  1000   C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   910   C0003212:steroidal anti-inflammatory drugs [Pharmacologic Substance,Steroid]
   884   C0003209:anti inflammatory drug [Pharmacologic Substance]
           Anti-inflammatory
   840   C1515999:Anti-inflammatory [Qualitative Concept]
   839   C0260264:steroid drug [Steroid]
   804   C0013227:Drug [Pharmacologic Substance]
   804   C0333348:Inflammatory [Functional Concept]
   804   C1254351:Drug [Pharmacologic Substance]
   804   C1518422:Non [Functional Concept]
   748 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   748 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   733   C0038317:Steroid [Steroid]
   711 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "("

Phrase: "s)"

Phrase: ","

Phrase: "nonsteroidal antiinflammatory drug"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
  1000   C0003211:Non-steroidal anti-inflammatory drug [Pharmacologic Substance]
  1000   C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   901   C0003209:anti inflammatory drug [Pharmacologic Substance]
           Anti-inflammatory
   827   C0013227:Drug [Pharmacologic Substance]
   827   C1254351:Drug [Pharmacologic Substance]
   827   C1515999:Anti-inflammatory [Qualitative Concept]
   771 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   771 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   734 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "("

Phrase: "s)."
Processing 00000000.tx.19: INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Many observational studies have investigated the association between use of nonsteroidal antiinflammatory drugs (NSAIDs) and risk of Alzheimers disease, dementia, and cognitive decline (130). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Many observational studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C1518527:Observational Study [Research Activity]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the association between use of nonsteroidal antiinflammatory drugs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "(NSAIDs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0003211:Nonsteroidal Anti-inflammatory Drugs [Pharmacologic Substance]
   988 E C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   901   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   827   C0013227:Drugs [Pharmacologic Substance]
   827   C1515999:Anti-inflammatory [Qualitative Concept]
   793 E C1254351:Drug [Pharmacologic Substance]
   755 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   755 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   727 E C0456386:Medicament [Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "risk of Alzheimers disease,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1281905:disease risk [Finding]
   770   C0035647:Risk [Qualitative Concept]

Phrase: "dementia,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "cognitive decline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]

Phrase: "(130"

Phrase: ")."
Processing 00000000.tx.20: Studies differed greatly in design, population, and exposure. 

Phrase: "Studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "differed"

Phrase: "greatly in design,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1707689:Design [Activity]
   790   C2983265:DESIGN [Intellectual Product]

Phrase: "population,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "and"

Phrase: "exposure."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]
Processing 00000000.tx.21: Many found an inverse association while others found no association. 

Phrase: "Many found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "an inverse association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1708567:Inverse Association [Conceptual Entity]
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "while"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no association."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]
Processing 00000000.tx.22: More recently, the results of a number of secondary prevention studies have been reported. 

Phrase: "More recently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "the results of a number of secondary prevention studies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0683954:results studies [Finding]
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708   C2825142:Result [Finding]

Phrase: "have"

Phrase: "been"

Phrase: "reported."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.23: Most of them showed no beneficial effect of use of NSAIDs on cognitive function (3133). 

Phrase: "Most of them"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205393:Most [Quantitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no beneficial effect of use of NSAIDs"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   784   C0728866:effect of drugs [Functional Concept]
           Drug effect
   770   C0542119:NO DRUG EFFECT [Finding]
   770   C0683156:beneficial drug effect [Biologic Function]
   762   C1301751:No effect [Qualitative Concept]
   762   C1515999:Anti-inflammatory effect [Qualitative Concept]
   762   C1516019:Antiinflammatory Effect [Physiologic Function]
   745   C0728867:Drug effect [Pathologic Function]
   745   C1411996:drug effect [Biologic Function]
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "on cognitive function"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0392335:cognitive function [Mental Process]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1516691:Cognitive [Functional Concept]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "(3133"

Phrase: ")."
Processing 00000000.tx.24: Results of primary prevention trials are not available. 

Phrase: "Results of primary prevention trials"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "are"

Phrase: "not available."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548671:Not available [Idea or Concept]
   861   C0470187:Available [Functional Concept]
Processing 00000000.tx.25: Hence, whether NSAIDs truly have a favorable effect in preventing dementia remains controversial (34). 

Phrase: "Hence,"

Phrase: "whether"

Phrase: "NSAIDs truly"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   923   C0003211:Nonsteroidal Anti-inflammatory Drugs [Pharmacologic Substance]
   912 E C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   861   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   812   C0013227:Drugs [Pharmacologic Substance]
   812   C1515999:Anti-inflammatory [Qualitative Concept]
   779 E C1254351:Drug [Pharmacologic Substance]
   741 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   741 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   712 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "have"

Phrase: "a favorable effect in preventing dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "remains"

Phrase: "controversial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0680243:controversies [Social Behavior]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.26: We performed a systematic review of the literature to summarize the epidemiologic evidence on the association between use of NSAIDs and the risk of dementia and to identify possible sources of heterogeneity between studies.  

Phrase: "We"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "a systematic review of the literature to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0282441:Review of Literature [Intellectual Product]
           Review Literature
   778   C1955832:Review, Systematic [Intellectual Product]
   748   C0220922:systematic [Functional Concept]
   748   C0282443:Review [Intellectual Product]
   748   C1552617:Review [Idea or Concept]

Phrase: "summarize"

Phrase: "the epidemiologic evidence on the association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332120:Evidence [Functional Concept]

Phrase: "between use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of NSAIDs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0003211:Nonsteroidal Anti-inflammatory Drugs [Pharmacologic Substance]
   988 E C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   901   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   827   C0013227:Drugs [Pharmacologic Substance]
   827   C1515999:Anti-inflammatory [Qualitative Concept]
   793 E C1254351:Drug [Pharmacologic Substance]
   755 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   755 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   727 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "and"

Phrase: "the risk of dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "possible sources of heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0449416:sources [Finding]
   737 E C1705919:Source [Idea or Concept]

Phrase: "between studies."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]
Processing 00000000.tx.27: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Systematic search We started by using a widely quoted 1996 review on NSAIDs and risk of Alzheimers disease (35) in two ways: 1) we evaluated the articles that were included in that review and 2) we used the Science Citation Index to identify studies that cited that review. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Systematic search"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1552603:search [Intellectual Product]
   861   C1706202:Search [Activity]

Phrase: "We"

Phrase: "started by"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1272689:Started [Qualitative Concept]
   799 E C0439659:Start [Temporal Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a widely"

Phrase: "quoted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2981735:Quote [Manufactured Object]

Phrase: "1996 review on NSAIDs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0282443:Review [Intellectual Product]
   753   C1552617:Review [Idea or Concept]

Phrase: "and"

Phrase: "risk of Alzheimers disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1281905:disease risk [Finding]
   770   C0035647:Risk [Qualitative Concept]

Phrase: "(35"

Phrase: ")"

Phrase: "in two ways"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "we"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706852:Article [Intellectual Product]

Phrase: "that"

Phrase: "were"

Phrase: "included in"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0332257:included [Functional Concept]
   833   C3538986:INCLUDED [Gene or Genome]
   799 E C1552866:include [Idea or Concept]
   799 E C2700399:Include [Activity]

Phrase: "that review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Science Citation Index to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0036397:Science [Occupation or Discipline]
   812   C0552371:Citation [Intellectual Product]
   812   C0918012:Index [Intellectual Product]
   812   C1552854:index [Idea or Concept]
   812   C1637833:% index [Quantitative Concept]

Phrase: "identify"

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "that"

Phrase: "cited"

Phrase: "that review."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]
Processing 00000000.tx.28: Next, we searched the MEDLINE database using the search term "NSAID" combined with "Alzheimers disease," "dementia," or "cognitive decline," limited to studies in humans. 

Phrase: "Next,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "we"

Phrase: "searched"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706202:Searched [Activity]
   966 E C1552603:search [Intellectual Product]

Phrase: "the MEDLINE database"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0242356:Database [Intellectual Product]
   861   C0993637:Data Base [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the search term ""NSAID"""
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   913   C0003211:Non-steroidal anti-inflammatory drug [Pharmacologic Substance]
   913   C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   849   C0003212:steroidal anti-inflammatory drugs [Pharmacologic Substance,Steroid]
   845   C0003209:anti inflammatory drug [Pharmacologic Substance]
           Anti-inflammatory
   818   C1515999:Anti-inflammatory [Qualitative Concept]
   810   C0260264:steroid drug [Steroid]
   795   C0013227:Drug [Pharmacologic Substance]
   795   C0333348:Inflammatory [Functional Concept]
   795   C1254351:Drug [Pharmacologic Substance]
   795   C1518422:Non [Functional Concept]
   740 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   740 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   724   C0038317:Steroid [Steroid]
   703 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "combined with ""Alzheimers disease,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   833   C0002395:Alzheimers disease [Disease or Syndrome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0205195:Combined [Qualitative Concept]
   737 E C0336789:Combine [Manufactured Object]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: """ ""dementia,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: """ or ""cognitive decline,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]

Phrase: """"

Phrase: "limited to studies"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0439801:Limited [Functional Concept]
   790   C0947630:studies [Laboratory Procedure]
   790   C3542948:Limited [Intellectual Product]
   756 E C0557651:Study [Manufactured Object]
   756 E C1549649:Limit [Idea or Concept]
   756 E C2349209:Limit [Conceptual Entity]
   756 E C2603343:Study [Research Activity]

Phrase: "in humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.29: We did not apply any language restriction. 

Phrase: "We"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "apply"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0185125:Apply [Health Care Activity]
  1000   C1632850:Apply [Functional Concept]
  1000   C1879355:Apply [Functional Concept]

Phrase: "any language restriction."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443288:Restriction [Functional Concept]
Processing 00000000.tx.30: Titles and abstracts of both search strategies were independently examined for eligibility by two of us (A. J. M. C. and J. G.). 

Phrase: "Titles"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C1519530:Title [Idea or Concept]
   966   C1704446:title [Idea or Concept]
   966   C1705823:Title [Intellectual Product]
   966   C1705824:TITLE [Intellectual Product]

Phrase: "and"

Phrase: "abstracts of both search strategies"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0000857:Abstract [Occupational Activity]
   760   C0600678:Abstract [Intellectual Product]
   760   C0679199:strategies [Mental Process]
   760   C1552603:search [Intellectual Product]
   760   C1552863:Abstract [Idea or Concept]
   760   C1706202:Search [Activity]

Phrase: "were"

Phrase: "independently"

Phrase: "examined for eligibility"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0013893:Eligibility [Health Care Activity]
   790   C0332128:Examined [Finding]
   718 E C1548635:eligible [Idea or Concept]

Phrase: "by two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "of us (A. J. M. C."

Phrase: "and"

Phrase: "J. G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.31: In case of doubt, the full article was retrieved and eligibility was discussed. 

Phrase: "In case of doubt,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870444:doubt [Mental Process]
   928 E C0750558:Doubtful [Conceptual Entity]

Phrase: "the full article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706852:Article [Intellectual Product]

Phrase: "was"

Phrase: "retrieved"

Phrase: "and"

Phrase: "eligibility"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013893:Eligibility [Health Care Activity]
   928 E C1548635:eligible [Idea or Concept]

Phrase: "was"

Phrase: "discussed."
Processing 00000000.tx.32: Both original articles and reviews were retrieved. 

Phrase: "Both original articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1706852:Article [Intellectual Product]

Phrase: "and"

Phrase: "reviews"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0282443:reviews [Intellectual Product]
   966 E C1552617:Review [Idea or Concept]

Phrase: "were"

Phrase: "retrieved."
Processing 00000000.tx.33: This whole process was repeated for references from identified studies and reviews. 

Phrase: "This whole process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "was"

Phrase: "repeated for references"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205341:Repeated [Functional Concept]
   756   C1514811:Reference [Idea or Concept]
   756 E C1547730:Repeat [Temporal Concept]
   756 E C1705914:Repeat [Conceptual Entity]
   756   C1706462:Reference [Conceptual Entity]

Phrase: "from identified studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "reviews."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0282443:reviews [Intellectual Product]
   966 E C1552617:Review [Idea or Concept]
Processing 00000000.tx.34: Eligibility criteria and data collection Studies were eligible for inclusion if they satisfied the following three criteria: 1) case-control or cohort study in humans, 2) exposure defined as use of NSAID, and 3) cases defined as Alzheimers disease, dementia, or cognitive impairment. 

Phrase: "Eligibility criteria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1512693:eligibility criteria [Qualitative Concept]
   861   C0243161:criteria [Intellectual Product]

Phrase: "and"

Phrase: "data collection Studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0010995:Data Collection [Research Activity]

Phrase: "were"

Phrase: "eligible for inclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1548635:eligible [Idea or Concept]

Phrase: "if"

Phrase: "they"

Phrase: "satisfied"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242428:Satisfied [Mental Process]

Phrase: "the following three criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0243161:criteria [Intellectual Product]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "case-control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0872128:case control [Health Care Activity]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "or"

Phrase: "cohort study in humans,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0009247:Cohort Study [Quantitative Concept]
   802   C0178693:human study [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C0599755:Cohort [Population Group]
   770   C2603343:Study [Research Activity]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]

Phrase: "defined as use of NSAID,"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   849   C0003211:Non-steroidal anti-inflammatory drug [Pharmacologic Substance]
   849   C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   790   C0003209:anti inflammatory drug [Pharmacologic Substance]
           Anti-inflammatory
   790   C0003212:steroidal anti-inflammatory drugs [Pharmacologic Substance,Steroid]
   764   C1515999:Anti-inflammatory [Qualitative Concept]
   764   C1524063:Use of [Functional Concept]
   762   C0242510:drug use [Mental or Behavioral Dysfunction]
   760   C0281991:use of steroids [Individual Behavior]
           Steroid Use
   742   C0013227:Drug [Pharmacologic Substance]
   742   C0042153:use [Functional Concept]
   742   C0333348:Inflammatory [Functional Concept]
   742   C0457083:Use [Functional Concept]
   742   C1254351:Drug [Pharmacologic Substance]
   742   C1518422:Non [Functional Concept]
   742   C1704788:Defined [Conceptual Entity]
   742   C1947944:Use [Intellectual Product]
   742   C3539106:Defined [Intellectual Product]
   726   C0260264:drug steroid [Steroid]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "defined as Alzheimers disease,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0002395:Alzheimers disease [Disease or Syndrome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1704788:Defined [Conceptual Entity]
   770   C3539106:Defined [Intellectual Product]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "dementia,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "or"

Phrase: "cognitive impairment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0338656:Cognitive impairment [Mental or Behavioral Dysfunction]
   861   C0684336:Impairment [Pathologic Function]
Processing 00000000.tx.35: Data were independently extracted from each study by two reviewers (A. J. M. C. and J. G.) using preprinted forms. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "independently"

Phrase: "extracted from each study"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
   770   C3541890:EXTRACTED [Finding]
   737 E C2828366:Extract [Substance]

Phrase: "by two reviewers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1709941:Reviewer [Qualitative Concept]
   827   C1882950:Reviewer [Population Group]

Phrase: "(A. J. M. C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C2346751:A/m [Quantitative Concept]

Phrase: "and"

Phrase: "J. G.)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "preprinted forms."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]
Processing 00000000.tx.36: We recorded study design, characteristics of exposure, definitions of cases and controls, prevalent or incident case ascertainment, total number of cases in the exposed group and total number of cases in the unexposed group, the measure of association (odds ratio, relative risk, or hazard ratio), the magnitude of the association with its corresponding 95 percent confidence interval, and the variables adjusted for in the analysis. 

Phrase: "We"

Phrase: "recorded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]

Phrase: "study design,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0035171:Study Design [Research Activity]
  1000   C2983265:Study Design [Intellectual Product]
           DESIGN
  1000   C2986888:Study Design [Research Activity]
   861   C0557651:Study [Manufactured Object]
   861   C1707689:Design [Activity]
   861   C2603343:Study [Research Activity]

Phrase: "characteristics of exposure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1521970:Characteristics [Qualitative Concept]

Phrase: "definitions of cases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1550452:definition [Idea or Concept]
   756   C1704788:Definition [Conceptual Entity]
   756   C3539107:Definition [Intellectual Product]

Phrase: "and"

Phrase: "controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "prevalent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   928   C0033105:Prevalence [Quantitative Concept]
   928   C0220900:prevalence [Quantitative Concept]

Phrase: "or"

Phrase: "incident case ascertainment,"

Phrase: "total number of cases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0237753:*Number [Quantitative Concept]
   770   C0439175:% total [Quantitative Concept]
   770   C0439810:Total [Qualitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "in the exposed group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C2348484:Exposed Group [Population Group]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "total number of cases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0237753:*Number [Quantitative Concept]
   770   C0439175:% total [Quantitative Concept]
   770   C0439810:Total [Qualitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "in the unexposed group,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C2349018:Unexposed Group [Population Group]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "the measure of association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079809:Measure [Quantitative Concept]
   770   C0242485:Measure [Functional Concept]

Phrase: "(odds ratio,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "relative risk,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242492:Relative Risk [Quantitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: "or"

Phrase: "hazard ratio"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2985465:Hazard Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C0598697:Hazard [Qualitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "the magnitude of the association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449286:magnitude [Quantitative Concept]
   760   C1704240:Magnitude [Quantitative Concept]

Phrase: "with its corresponding 95 percent confidence interval,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   840   C0009667:Confidence Interval [Quantitative Concept]
   804   C0237529:Confidence [Mental Process]
   804   C1272706:Interval [Temporal Concept]
   804   C1552654:Interval [Idea or Concept]
   804   C1552713:Interval [Intellectual Product]
   804   C1704725:Confidence [Qualitative Concept]
   804   C1704726:Confidence [Mental Process]
   733 E C0558095:Confident [Individual Behavior]
   704 E C0009669:confidentiality [Idea or Concept]

Phrase: "and"

Phrase: "the variables"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439828:variables [Qualitative Concept]

Phrase: "adjusted for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0456081:Adjusted [Functional Concept]

Phrase: "in the analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]
Processing 00000000.tx.37: When separate results were reported within one study for both Alzheimers disease and dementia, the results for dementia were recorded. 

Phrase: "When"

Phrase: "separate results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "reported within one study"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   802   C1317750:Study report [Intellectual Product]
   802   C1831145:Study report [Clinical Attribute]
   770   C0205447:One [Quantitative Concept]
   770   C0557651:Study [Manufactured Object]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C2603343:Study [Research Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "for both Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "dementia,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "the results for dementia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "were"

Phrase: "recorded."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]
Processing 00000000.tx.38: When varying levels of NSAID use were reported, we took the results for the largest group of NSAID users. 

Phrase: "When"

Phrase: "varying levels of NSAID use"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   762   C0428212:drug levels [Laboratory or Test Result]
   762   C1261153:drug levels [Laboratory Procedure]
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: ","

Phrase: "we"

Phrase: "took"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515187:Take [Health Care Activity]

Phrase: "the results for the largest group"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "of NSAID users."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0338666:Drug Users [Patient or Disabled Group]
   799   C1706077:Users [Human]
   780   C0003211:Non-steroidal anti-inflammatory drug [Pharmacologic Substance]
   780   C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   766 E C1548600:User [Idea or Concept]
   706   C0003212:steroidal anti-inflammatory drugs [Pharmacologic Substance,Steroid]
Processing 00000000.tx.39: Statistical analysis Results of cohort studies were typically expressed as relative risk or hazard ratio, while results of case-control studies were usually expressed as odds ratio. 

Phrase: "Statistical analysis Results of cohort studies"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   798   C0681874:study analysis result [Research Activity]
   783   C0683954:results studies [Finding]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "were"

Phrase: "typically"

Phrase: "expressed as relative risk"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0242492:Relative Risk [Quantitative Concept]
   770   C0035647:Risk [Qualitative Concept]
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]

Phrase: "or"

Phrase: "hazard ratio,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2985465:Hazard Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C0598697:Hazard [Qualitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "while"

Phrase: "results of case-control studies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0683954:results studies [Finding]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "were"

Phrase: "usually"

Phrase: "expressed as odds ratio."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0028873:Odds Ratio [Quantitative Concept]
   770   C0456603:Ratio [Quantitative Concept]
   770   C1547037:Ratio [Intellectual Product]
Processing 00000000.tx.40: A hazard ratio is the ratio of instantaneous probability of the outcome event (Alzheimers disease, dementia, or cognitive decline) in the exposed group compared with that in the nonexposed group and can be considered a relative risk. 

Phrase: "A hazard ratio"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2985465:Hazard Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C0598697:Hazard [Qualitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "is"

Phrase: "the ratio of instantaneous probability of the outcome event"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0456603:Ratio [Quantitative Concept]
   742   C1547037:Ratio [Intellectual Product]

Phrase: "(Alzheimers disease,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "dementia,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "or"

Phrase: "cognitive decline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]

Phrase: ")"

Phrase: "in the exposed group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C2348484:Exposed Group [Population Group]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "compared with that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "in the nonexposed group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "can"

Phrase: "be"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "a relative risk."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242492:Relative Risk [Quantitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.41: Because dementia is a rare event (<5 percent), odds ratios from case-control studies are also good estimates for the relative risk. 

Phrase: "Because"

Phrase: "dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "is"

Phrase: "a rare event"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441471:Event [Event]

Phrase: "("

Phrase: "<5 percent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439165:Percent [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "odds ratios from case-control studies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0028873:Odds Ratios [Quantitative Concept]
   753   C0456603:Ratios [Quantitative Concept]
   753   C1610540:*Ratios [Quantitative Concept]
   719 E C1547037:Ratio [Intellectual Product]

Phrase: "are"

Phrase: "also good estimates for the relative risk."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1519101:Risk Estimate [Quantitative Concept]
   748   C0750572:estimates [Quantitative Concept]
Processing 00000000.tx.42: For simplicity, we refer to relative risk for all three types of measures of association. 

Phrase: "For simplicity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0205352:Simple [Qualitative Concept]

Phrase: "we"

Phrase: "refer to relative risk"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0242492:Relative Risk [Quantitative Concept]
   770   C0035647:Risk [Qualitative Concept]
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C0205543:refer [Functional Concept]
   770   C1547039:*Relative [Quantitative Concept]

Phrase: "for all three types"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332307:Types [Qualitative Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "of measures"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0079809:Measures [Quantitative Concept]
  1000   C1879489:Measures [Functional Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "of association."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]
Processing 00000000.tx.43: The logarithm of the relative risk with its corresponding standard error, taken directly from the studies or calculated from the reported 95 percent confidence interval, provided the data points for the meta-analysis. 

Phrase: "The logarithm of the relative risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2986775:Logarithm [Occupational Activity]

Phrase: "with its corresponding standard error,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1710181:Standard Error [Quantitative Concept]
   827   C0743559:error [Qualitative Concept]
   827   C1442989:Standard [Qualitative Concept]
   827   C1608199:Error [Functional Concept]
   827   C2828392:Standard [Intellectual Product]

Phrase: "taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "directly from the studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0947630:studies [Laboratory Procedure]
   770   C1947931:Directly [Qualitative Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "or"

Phrase: "calculated from the reported 95 percent confidence interval,"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   770   C0009667:Confidence Interval [Quantitative Concept]
   744   C0237529:Confidence [Mental Process]
   744   C0439165:Percent [Quantitative Concept]
   744   C0444686:Calculated [Functional Concept]
   744   C0684224:Reported [Intellectual Product]
   744   C0700287:Reported [Health Care Activity]
   744   C1272706:Interval [Temporal Concept]
   744   C1441506:Calculated [Activity]
   744   C1443182:Calculated [Laboratory Procedure]
   744   C1552654:Interval [Idea or Concept]
   744   C1552713:Interval [Intellectual Product]
   744   C1704725:Confidence [Qualitative Concept]
   744   C1704726:Confidence [Mental Process]
   744   C3496591:Reported [Clinical Attribute]
   711 E C3273238:Report [Intellectual Product]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "points for the meta-analysis."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0282458:Meta-Analysis [Intellectual Product]
   806   C0920317:Meta-Analysis [Research Activity]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1042496:Meta [Eukaryote]
   760   C1524024:analysis [Functional Concept]
   760   C1552961:Point [Quantitative Concept]
   760   C2347617:point [Quantitative Concept]
Processing 00000000.tx.44: We used the DerSimonian and Laird (36) random effects model to compute pooled relative risks and to assess statistical heterogeneity. 

Phrase: "We"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the DerSimonian"

Phrase: "and"

Phrase: "Laird"

Phrase: "(36"

Phrase: ")"

Phrase: "random effects model to"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0034656:RANDOM [Research Activity]
   812   C0439605:Random [Qualitative Concept]
   812   C1280500:effects [Qualitative Concept]
   812   C3161035:Model [Intellectual Product]
   779 E C2348382:Effect [Qualitative Concept]

Phrase: "compute"

Phrase: "pooled relative risks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0242492:Risks, Relative [Quantitative Concept]
   827   C0035647:Risks [Qualitative Concept]
   827   C0080103:Relative [Family Group]
   827   C0205345:Relative [Qualitative Concept]
   827   C1547039:*Relative [Quantitative Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "statistical heterogeneity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0019409:Heterogeneity [Qualitative Concept]
   777 E C1512426:Heterogenous [Idea or Concept]
Processing 00000000.tx.45: We did not exclude outliers simply on the basis of the statistical test, because heterogeneity is expected in a meta-analysis of epidemiologic studies, but we searched for the sources (i.e., methodological or biologic). 

Phrase: "We"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "outliers simply on the basis of the statistical test,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C2698674:Outlier [Quantitative Concept]

Phrase: "because"

Phrase: "heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019409:Heterogeneity [Qualitative Concept]
   916 E C1512426:Heterogenous [Idea or Concept]

Phrase: "is"

Phrase: "expected in a meta-analysis of epidemiologic studies,"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   770   C0002783:Epidemiologic Studies [Research Activity]
   770   C0282458:Meta-Analysis [Intellectual Product]
   770   C0920317:Meta-Analysis [Research Activity]
   758   C0699910:Study of epidemiology [Health Care Activity]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0014507:Epidemiologic [Biomedical Occupation or Discipline]
   744   C0014508:epidemiologic [Functional Concept]
   744   C0936012:Analysis [Research Activity]
   744   C0947630:studies [Laboratory Procedure]
   744   C1042496:Meta [Eukaryote]
   744   C1517001:Expected [Idea or Concept]
   744   C1524024:analysis [Functional Concept]
   711 E C0557651:Study [Manufactured Object]
   711 E C2603343:Study [Research Activity]

Phrase: "but"

Phrase: "we"

Phrase: "searched for the sources"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0449416:sources [Finding]
   770   C1706202:Searched [Activity]
   737 E C1552603:search [Intellectual Product]
   737 E C1705919:Source [Idea or Concept]

Phrase: "(i.e., methodological"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   755   C0969625:methodology [Intellectual Product]
   755   C3266812:Methodology [Idea or Concept]
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: "or"

Phrase: "biologic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205460:Biologic [Qualitative Concept]
  1000   C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.46: Subgroup and sensitivity analyses were carried out when appropriate. 

Phrase: "Subgroup"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1079230:subgroup [Virus]
  1000   C1515021:Subgroup [Classification]

Phrase: "and"

Phrase: "sensitivity analyses"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   861   C0036667:Sensitivity [Quantitative Concept]
   861   C0312418:Sensitivity [Mental Process]
   861   C0427965:Sensitivity [Finding]
   861   C1511883:Sensitivity [Quantitative Concept]
   861   C1522640:Sensitivity [Qualitative Concept]
   861   C2346484:SENSITIVITY [Phenomenon or Process]
   861   C2349185:Sensitivity [Qualitative Concept]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   789 E C0332324:Sensitive [Functional Concept]
   789 E C1550474:sensitive [Idea or Concept]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "when"

Phrase: "appropriate."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548787:Appropriate [Qualitative Concept]
   928 E C0814634:appropriateness [Qualitative Concept]
Processing 00000000.tx.47: We evaluated publication bias by means of visual inspection of funnel plots and formal statistical testing (37). 

Phrase: "We"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "publication bias by means of visual inspection of funnel plots"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0206086:Publication Bias [Qualitative Concept]
   739   C0242568:Bias [Idea or Concept]
   739   C1504315:Bias [Bird]
   706 E C1061346:Bia [Eukaryote]
   706 E C1704746:BIA [Diagnostic Procedure]

Phrase: "and"

Phrase: "formal statistical testing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   877   C0871508:forms testing [Manufactured Object]
   827   C0039593:Testing [Functional Concept]
   827   C0392366:testing [Intellectual Product]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.48: In a funnel plot, the relative risk of the study is displayed against the weight of the study, which is the inverse of the square of the standard error. 

Phrase: "In a funnel plot,"

Phrase: "the relative risk of the study"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0242492:Relative Risk [Quantitative Concept]
   753   C0035647:Risk [Qualitative Concept]
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "is"

Phrase: "displayed against the weight of the study,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0005910:weight [Organism Attribute]
   748   C0043100:Weight [Quantitative Concept]
   748   C0557651:Study [Manufactured Object]
   748   C0870432:displayed [Functional Concept]
   748   C1305866:weight [Diagnostic Procedure]
   748   C1705104:Weight [Idea or Concept]
   748   C2603343:Study [Research Activity]
   714 E C1705417:Display [Manufactured Object]

Phrase: "which"

Phrase: "is"

Phrase: "the inverse of the square of the standard error."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0439850:Inverse [Qualitative Concept]
Processing 00000000.tx.49: Funnel plots generally show a peak. 

Phrase: "Funnel"

Phrase: "plots"

Phrase: "generally"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a peak."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444505:Peak [Quantitative Concept]
Processing 00000000.tx.50: This is the point where the studies with smaller standard errors are found and usually represents the point of the approximate true effect. 

Phrase: "This"

Phrase: "is"

Phrase: "the point where"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]

Phrase: "the studies with smaller standard errors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0947630:studies [Laboratory Procedure]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "usually"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the point of the approximate true effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1552961:Point [Quantitative Concept]
   748   C2347617:point [Quantitative Concept]
Processing 00000000.tx.51: Formal statistical assessment of funnel plot asymmetry was done with linear regression analysis, where the log odds ratio divided by its standard error was regressed against the inverse of the standard error (37). 

Phrase: "Formal statistical assessment of funnel plot asymmetry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1261322:Assessment [Health Care Activity]
   748   C1516048:Assessment [Activity]

Phrase: "was"

Phrase: "done with linear regression analysis,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C0023733:Linear Regression [Quantitative Concept]
   806   C0034980:Regression Analysis [Intellectual Product]
   806   C2346679:Linear Regression [Intellectual Product]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0205132:Linear [Spatial Concept]
   760   C0684320:Regression [Pathologic Function]
   760   C0684321:Regression [Mental Process]
   760   C0936012:Analysis [Research Activity]
   760   C1272695:Done [Qualitative Concept]
   760   C1524024:analysis [Functional Concept]
   760   C2746065:Done [Temporal Concept]

Phrase: "where"

Phrase: "the log odds ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0028873:Odds Ratio [Quantitative Concept]
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]

Phrase: "divided by its standard error"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1710181:Standard Error [Quantitative Concept]
   760   C0332849:Divided [Functional Concept]
   760   C0743559:error [Qualitative Concept]
   760   C1442989:Standard [Qualitative Concept]
   760   C1608199:Error [Functional Concept]
   760   C2828392:Standard [Intellectual Product]

Phrase: "was"

Phrase: "regressed against the inverse of the standard error"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1710181:Standard Error [Quantitative Concept]
   744   C0439850:Inverse [Qualitative Concept]
   744   C0743559:error [Qualitative Concept]
   744   C1442989:Standard [Qualitative Concept]
   744   C1608199:Error [Functional Concept]
   744   C2828392:Standard [Intellectual Product]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.52: Reported p values are from the intercept of the regression analysis, which provides a measure of asymmetry. 

Phrase: "Reported p values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   867   C1709380:P-Value [Quantitative Concept]
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "are from the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1551058:Are [Quantitative Concept]

Phrase: "intercept of the regression analysis,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0034980:Regression Analysis [Intellectual Product]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0598981:Intercept [Organic Chemical,Pharmacologic Substance]
   760   C0684320:Regression [Pathologic Function]
   760   C0684321:Regression [Mental Process]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C3146232:Intercept [Quantitative Concept]

Phrase: "which"

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a measure of asymmetry."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079809:Measure [Quantitative Concept]
   770   C0242485:Measure [Functional Concept]
Processing 00000000.tx.53: Case-control studies with incident dementia cases and cohort studies were classified as studies with incident cases. 

Phrase: "Case-control studies with incident dementia cases"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   814   C0007328:Case-Control Studies [Research Activity]
   778   C0872128:case control [Health Care Activity]
   774   C0085973:Case Studies [Intellectual Product]
   748   C0243148:control [Qualitative Concept]
   748   C0868928:Case [Functional Concept]
   748   C0947630:studies [Laboratory Procedure]
   748   C1550141:Control [Substance]
   748   C1706255:CASE [Medical Device]
   748   C1706256:Case [Conceptual Entity]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
   714 E C0557651:Study [Manufactured Object]
   714 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "cohort studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0009247:Cohort Studies [Quantitative Concept]
   861   C0599755:Cohort [Population Group]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "classified as studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0008902:Classified [Classification]
   790   C0947630:studies [Laboratory Procedure]
   756 E C0557651:Study [Manufactured Object]
   756 E C2603343:Study [Research Activity]

Phrase: "with incident cases."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   861   C1551358:incident [Idea or Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.54: Studies where cognition was the main outcome of interest among users and nonusers of NSAIDs were classified as studies with cognitive decline cases.  

Phrase: "Studies where cognition"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0009240:Cognition [Mental Process]
   743 E C2981149:Intellect [Mental Process]
   734 E C0233698:Noesis [Mental or Behavioral Dysfunction]

Phrase: "was"

Phrase: "the main outcome of interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1274040:Outcome [Functional Concept]

Phrase: "among users"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706077:Users [Human]
   966 E C1548600:User [Idea or Concept]

Phrase: "and"

Phrase: "nonusers of NSAIDs"

Phrase: "were"

Phrase: "classified as studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0008902:Classified [Classification]
   790   C0947630:studies [Laboratory Procedure]
   756 E C0557651:Study [Manufactured Object]
   756 E C2603343:Study [Research Activity]

Phrase: "with cognitive decline cases."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]
   734   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]
Processing 00000000.tx.55: RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Searching the Science Citation Index yielded 402 publications referring to the review of McGeer et al. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1514811:Reference [Idea or Concept]
   779   C1706462:Reference [Conceptual Entity]

Phrase: "Searching"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1552603:search [Intellectual Product]
   966   C1706202:Search [Activity]

Phrase: "the Science Citation Index"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0036397:Science [Occupation or Discipline]
   827   C0552371:Citation [Intellectual Product]
   827   C0918012:Index [Intellectual Product]
   827   C1552854:index [Idea or Concept]
   827   C1637833:% index [Quantitative Concept]

Phrase: "yielded"

Phrase: "402 publications"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0034036:Publications [Intellectual Product,Manufactured Object]
   827 E C0034037:Publication [Occupational Activity]
   827 E C1704324:Publication [Intellectual Product]

Phrase: "referring to the review of McGeer et al."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0205543:Referring [Functional Concept]
   744   C0282443:Review [Intellectual Product]
   744   C1552617:Review [Idea or Concept]
Processing 00000000.tx.56: (35), and the MEDLINE search yielded 337 publications. 

Phrase: "(35"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the MEDLINE search"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1552603:search [Intellectual Product]
   861   C1706202:Search [Activity]

Phrase: "yielded"

Phrase: "337 publications."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0034036:Publications [Intellectual Product,Manufactured Object]
   827 E C0034037:Publication [Occupational Activity]
   827 E C1704324:Publication [Intellectual Product]
Processing 00000000.tx.57: After retrieval of potential articles and subsequent discussion, we found 30 studies meeting our eligibility criteria (130). 

Phrase: "After retrieval"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514918:Retrieval [Health Care Activity]

Phrase: "of potential articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1706852:Article [Intellectual Product]

Phrase: "and"

Phrase: "subsequent discussion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557061:Discussion [Therapeutic or Preventive Procedure]
   861   C2584313:Discussion [Social Behavior]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "30 studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "meeting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0556656:Meeting [Health Care Activity]
   966 E C1550543:Meet [Idea or Concept]

Phrase: "our eligibility criteria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1512693:eligibility criteria [Qualitative Concept]
   861   C0243161:criteria [Intellectual Product]

Phrase: "(130"

Phrase: ")."
Processing 00000000.tx.58: Four studies (14) were excluded because a relative risk could not be extracted from the report (one study did not report on the association (1), two studies found no association (2, 3), and one study compared the cognitive function of patients who had Alzheimers disease and were taking NSAIDs with that of patients who had Alzheimers disease and were not taking NSAIDs (4)), and one study (5) was excluded because it was based on the same data as another publication. 

Phrase: "Four studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "(14"

Phrase: ")"

Phrase: "were"

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: "because"

Phrase: "a relative risk"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242492:Relative Risk [Quantitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "extracted from the report"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C0684224:Report [Intellectual Product]
   770   C0700287:Report [Health Care Activity]
   770   C3273238:Report [Intellectual Product]
   770   C3541890:EXTRACTED [Finding]
   737 E C2828366:Extract [Substance]

Phrase: "(one study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "report on the association"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0684224:Report [Intellectual Product]
   770   C0699792:association [Social Behavior]
   770   C0700287:Report [Health Care Activity]
   770   C3273238:Report [Intellectual Product]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "two studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "one study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "the cognitive function of patients"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0392335:cognitive function [Mental Process]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1516691:Cognitive [Functional Concept]
   760   C1705273:Function [Intellectual Product]

Phrase: "who"

Phrase: "had"

Phrase: "Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "were"

Phrase: "taking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515187:Take [Health Care Activity]

Phrase: "NSAIDs with that of patients"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   814   C0003211:Nonsteroidal Anti-inflammatory Drugs [Pharmacologic Substance]
   802 E C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   778   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   748   C0013227:Drugs [Pharmacologic Substance]
   748   C1515999:Anti-inflammatory [Qualitative Concept]
   714 E C1254351:Drug [Pharmacologic Substance]

Phrase: "who"

Phrase: "had"

Phrase: "Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "taking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515187:Take [Health Care Activity]

Phrase: "NSAIDs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0003211:Nonsteroidal Anti-inflammatory Drugs [Pharmacologic Substance]
   988 E C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   901   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   827   C0013227:Drugs [Pharmacologic Substance]
   827   C1515999:Anti-inflammatory [Qualitative Concept]
   793 E C1254351:Drug [Pharmacologic Substance]
   755 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   755 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   727 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "(4"

Phrase: ")"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "one study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: "because"

Phrase: "it"

Phrase: "was"

Phrase: "based on the same data"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   781   C0242356:data base [Intellectual Product]
   781   C0993637:Data Base [Intellectual Product]
   760   C0445247:Same [Qualitative Concept]
   760   C1511726:Data [Idea or Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   760   C3245479:data [Medical Device]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "as another publication."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034036:Publication [Intellectual Product,Manufactured Object]
  1000   C0034037:Publication [Occupational Activity]
  1000   C1704324:Publication [Intellectual Product]
Processing 00000000.tx.59: Descriptive details of the remaining 25 studies included in our meta-analysis are presented in table 1. 

Phrase: "Descriptive details of the remaining 25 studies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1522508:Details [Qualitative Concept]
   714 E C1561567:detail [Functional Concept]

Phrase: "included in our meta-analysis"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0282458:Meta-Analysis [Intellectual Product]
   806   C0920317:Meta-Analysis [Research Activity]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0332257:included [Functional Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1042496:Meta [Eukaryote]
   760   C1524024:analysis [Functional Concept]
   760   C3538986:INCLUDED [Gene or Genome]
   726 E C1552866:include [Idea or Concept]
   726 E C2700399:Include [Activity]

Phrase: "are"

Phrase: "presented in table 1."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C0449450:Presented [Idea or Concept]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.60: Eleven studies used prevalent cases (616), 10 studies used incident cases (1726), and four studies used cognitive decline as clinical outcome (2730). 

Phrase: "Eleven"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205457:Eleven [Quantitative Concept]
  1000   C0445482:Eleven [Organism Attribute]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "used prevalent cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "(616"

Phrase: ")"

Phrase: ","

Phrase: "10 studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "incident cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   861   C1551358:incident [Idea or Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "(1726"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "four"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205450:Four [Quantitative Concept]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "used cognitive decline as clinical outcome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]

Phrase: "(2730"

Phrase: ")."
Processing 00000000.tx.61: Both the definition and length of exposure of use of NSAIDs varied among studies. 

Phrase: "Both"

Phrase: "the definition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550452:definition [Idea or Concept]
  1000   C1704788:Definition [Conceptual Entity]
  1000   C3539107:Definition [Intellectual Product]

Phrase: "and"

Phrase: "length of exposure of use of NSAIDs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1444754:Length [Quantitative Concept]
   742   C1706316:LENGTH [Research Activity]

Phrase: "varied among studies."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0947630:studies [Laboratory Procedure]
   756 E C0557651:Study [Manufactured Object]
   756 E C2603343:Study [Research Activity]
Processing 00000000.tx.62: View this table: [in this window] [in a new window]  TABLE 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.63: Description of studies on the use of nonsteroidal antiinflammatory drugs and risk of dementia  Table 2 presents the individual relative risks of all 25 retrieved studies. 

Phrase: "Description of studies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0678257:Description [Idea or Concept]

Phrase: "on the use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of nonsteroidal antiinflammatory drugs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0003211:Nonsteroidal Anti-inflammatory Drugs [Pharmacologic Substance]
   988 E C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   901   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   827   C0013227:Drugs [Pharmacologic Substance]
   827   C1515999:Anti-inflammatory [Qualitative Concept]
   793 E C1254351:Drug [Pharmacologic Substance]
   755 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   755 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   727 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "and"

Phrase: "risk of dementia  Table 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035647:Risk [Qualitative Concept]

Phrase: "presents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "the individual relative risks of all 25 retrieved studies."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0242492:Risks, Relative [Quantitative Concept]
   742   C0035647:Risks [Qualitative Concept]
   742   C0080103:Relative [Family Group]
   742   C0205345:Relative [Qualitative Concept]
   742   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.64: We divided the reports into studies with prevalent cases, studies with incident cases, and studies with cognitive decline as the endpoint. 

Phrase: "We"

Phrase: "divided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332849:Divided [Functional Concept]

Phrase: "the reports into studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   819   C1317750:reports studies [Intellectual Product]
   786 E C1831145:Study report [Clinical Attribute]
   770   C0684224:Reports [Intellectual Product]
   770   C0700287:reports [Health Care Activity]
   737 E C3273238:Report [Intellectual Product]

Phrase: "with prevalent cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "studies with incident cases,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   802   C0085973:Case Studies [Intellectual Product]
   770   C0557651:Study [Manufactured Object]
   770   C0868928:Cases [Functional Concept]
   770   C0947630:studies [Laboratory Procedure]
   770   C1533148:Cases [Quantitative Concept]
   770   C1551358:incident [Idea or Concept]
   770   C2603343:Study [Research Activity]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "studies with cognitive decline"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]
   770   C0557651:Study [Manufactured Object]
   770   C0947630:studies [Laboratory Procedure]
   770   C1516691:Cognitive [Functional Concept]
   770   C2603343:Study [Research Activity]

Phrase: "as the endpoint."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2349179:End Point [Qualitative Concept]
  1000   C2826544:ENDPOINT [Quantitative Concept]
Processing 00000000.tx.65: The funnel plot (figure 1) shows the relative risks of the 25 studies plotted against their weights. 

Phrase: "The funnel plot"

Phrase: "(figure 1"

Phrase: ")"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the relative risks of the 25 studies"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0242492:Risks, Relative [Quantitative Concept]
   748   C0035647:Risks [Qualitative Concept]
   748   C0080103:Relative [Family Group]
   748   C0205345:Relative [Qualitative Concept]
   748   C1547039:*Relative [Quantitative Concept]

Phrase: "plotted against their weights."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0043100:Weights [Quantitative Concept]
   737 E C0005910:weight [Organism Attribute]
   737 E C1305866:weight [Diagnostic Procedure]
   737 E C1705104:Weight [Idea or Concept]
Processing 00000000.tx.66: A relative risk smaller than one indicates that use of NSAIDs is beneficial. 

Phrase: "A relative risk"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242492:Relative Risk [Quantitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: "smaller than one"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0547044:Smaller [Qualitative Concept]
   790   C0700321:Smaller [Quantitative Concept]

Phrase: "indicates"

Phrase: "that use of NSAIDs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1524063:Use of [Functional Concept]
   767   C0242510:drug use [Mental or Behavioral Dysfunction]
   753   C0042153:use [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]

Phrase: "is"

Phrase: "beneficial."
Processing 00000000.tx.67: The pooled relative risks of these three groups of studies were 0.51 (95 percent confidence interval (CI): 0.37, 0.70) for studies with prevalent dementia cases, 0.79 (95 percent CI: 0.68, 0.92) for studies with incident dementia cases, and 1.23 (95 percent CI: 0.70, 2.31) for studies with cognitive decline as the endpoint. 

Phrase: "The pooled relative risks of these three groups of studies"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0242492:Risks, Relative [Quantitative Concept]
   739   C0035647:Risks [Qualitative Concept]
   739   C0080103:Relative [Family Group]
   739   C0205345:Relative [Qualitative Concept]
   739   C1547039:*Relative [Quantitative Concept]

Phrase: "were"

Phrase: "0.51"

Phrase: "(95 percent confidence interval"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: "(CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0009667:Confidence Interval [Quantitative Concept]
   861   C0237529:Confidence [Mental Process]
   861   C1272706:Interval [Temporal Concept]
   861   C1552654:Interval [Idea or Concept]
   861   C1552713:Interval [Intellectual Product]
   861   C1704725:Confidence [Qualitative Concept]
   861   C1704726:Confidence [Mental Process]
   789 E C0558095:Confident [Individual Behavior]
   761 E C0009669:confidentiality [Idea or Concept]

Phrase: ")"

Phrase: ":"

Phrase: "0.37,"

Phrase: "0.70"

Phrase: ")"

Phrase: "for studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "with prevalent dementia cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "0.79"

Phrase: "(95 percent CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.68,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450387:68 [Intellectual Product]

Phrase: "0.92"

Phrase: ")"

Phrase: "for studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "with incident dementia cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "1.23"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0450348:23 [Quantitative Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(95 percent CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.70,"

Phrase: "2.31"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0450355:31 [Intellectual Product]
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "for studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "with cognitive decline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]

Phrase: "as the endpoint."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2349179:End Point [Qualitative Concept]
  1000   C2826544:ENDPOINT [Quantitative Concept]
Processing 00000000.tx.68: Within these subgroups, heterogeneity was present in the studies with prevalent cases (p = 0.001) but not in the studies with incident cases (p = 0.60). 

Phrase: "Within these subgroups,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1079230:subgroups [Virus]
   966 E C1515021:Subgroup [Classification]

Phrase: "heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019409:Heterogeneity [Qualitative Concept]
   916 E C1512426:Heterogenous [Idea or Concept]

Phrase: "was"

Phrase: "present in the studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "with prevalent cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "(p = 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "but"

Phrase: "not in the studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0947630:studies [Laboratory Procedure]
   770   C1518422:Not [Functional Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "with incident cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   861   C1551358:incident [Idea or Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "(p = 0.60"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.69: Statistical testing for heterogeneity of studies where cognitive decline was used as the endpoint gave a p value of 0.08. 

Phrase: "Statistical testing for heterogeneity of studies where cognitive decline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0039593:Testing [Functional Concept]
   742   C0392366:testing [Intellectual Product]

Phrase: "was"

Phrase: "used as the endpoint"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C1273517:used [Finding]
   770   C2349179:End Point [Qualitative Concept]
   770   C2826544:ENDPOINT [Quantitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "a p value of 0.08."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1709380:P-Value [Quantitative Concept]
   753   C1522609:Value [Quantitative Concept]
Processing 00000000.tx.70: Within the three subgroups, there was an indication for the presence of publication bias in the studies with prevalent cases (p = 0.04), whereas there was no indication in the studies with incident cases (p = 0.96) or in the studies where cognitive decline was used as the endpoint (p = 0.38). 

Phrase: "Within the three subgroups,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1079230:subgroups [Virus]
   827 E C1515021:Subgroup [Classification]

Phrase: "there"

Phrase: "was"

Phrase: "an indication for the presence of publication bias"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392360:indication [Idea or Concept]
   744   C3146298:Indication [Functional Concept]

Phrase: "in the studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "with prevalent cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "(p = 0.04"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "there"

Phrase: "was"

Phrase: "no indication in the studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392360:indication [Idea or Concept]
   760   C3146298:Indication [Functional Concept]

Phrase: "with incident cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   861   C1551358:incident [Idea or Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "(p = 0.96"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "or in the studies where cognitive decline"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   778   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]
   748   C0947630:studies [Laboratory Procedure]
   748   C1516691:Cognitive [Functional Concept]
   714 E C0557651:Study [Manufactured Object]
   714 E C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "used as the endpoint"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C1273517:used [Finding]
   770   C2349179:End Point [Qualitative Concept]
   770   C2826544:ENDPOINT [Quantitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "(p = 0.38"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.71: View this table: [in this window] [in a new window]  TABLE 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.72: Summary results of studies on the use of nonsteroidal antiinflammatory drugs and risk of dementia  View larger version (10K): [in this window] [in a new window]  FIGURE 1. 

Phrase: "Summary"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "results of studies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   858   C0683954:results studies [Finding]
   790   C0947630:studies [Laboratory Procedure]
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]
   756 E C0557651:Study [Manufactured Object]
   756 E C2603343:Study [Research Activity]

Phrase: "on the use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of nonsteroidal antiinflammatory drugs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0003211:Nonsteroidal Anti-inflammatory Drugs [Pharmacologic Substance]
   988 E C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   901   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   827   C0013227:Drugs [Pharmacologic Substance]
   827   C1515999:Anti-inflammatory [Qualitative Concept]
   793 E C1254351:Drug [Pharmacologic Substance]
   755 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   755 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   727 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "and"

Phrase: "risk of dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0035647:Risk [Qualitative Concept]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(10K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 1."
Processing 00000000.tx.73: Funnel plot of relative risks of 25 studies of use of nonsteroidal antiinflammatory drugs and risk of dementia. 

Phrase: "Funnel plot of relative risks of 25 studies of use of nonsteroidal antiinflammatory drugs"

Phrase: "and"

Phrase: "risk of dementia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.74: "Weight" is the study weight calculated from the inverse of the square of the standard error of the log relative risk.  

Phrase: """Weight"""
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005910:weight [Organism Attribute]
  1000   C0043100:Weight [Quantitative Concept]
  1000   C1305866:weight [Diagnostic Procedure]
  1000   C1705104:Weight [Idea or Concept]

Phrase: "is"

Phrase: "the study weight"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0005910:weight [Organism Attribute]
   861   C0043100:Weight [Quantitative Concept]
   861   C1305866:weight [Diagnostic Procedure]
   861   C1705104:Weight [Idea or Concept]

Phrase: "calculated from the inverse of the square of the standard error"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   756   C1710181:Standard Error [Quantitative Concept]
   738   C0205120:Square [Spatial Concept]
   738   C0439850:Inverse [Qualitative Concept]
   738   C0444686:Calculated [Functional Concept]
   738   C0743559:error [Qualitative Concept]
   738   C1441506:Calculated [Activity]
   738   C1442989:Standard [Qualitative Concept]
   738   C1443182:Calculated [Laboratory Procedure]
   738   C1552595:Square [Intellectual Product]
   738   C1608199:Error [Functional Concept]
   738   C2828392:Standard [Intellectual Product]

Phrase: "of the log relative risk."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0242492:Relative Risk [Quantitative Concept]
   827   C0035647:Risk [Qualitative Concept]
   827   C0080103:Relative [Family Group]
   827   C0205345:Relative [Qualitative Concept]
   827   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.75: Furthermore, we analyzed the case-control studies with incident dementia cases and cohort studies separately. 

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the case-control studies with incident dementia cases"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   800   C0007328:Case-Control Studies [Research Activity]
   770   C0872128:case control [Health Care Activity]
   767   C0085973:Case Studies [Intellectual Product]
   744   C0243148:control [Qualitative Concept]
   744   C0868928:Case [Functional Concept]
   744   C0947630:studies [Laboratory Procedure]
   744   C1550141:Control [Substance]
   744   C1706255:CASE [Medical Device]
   744   C1706256:Case [Conceptual Entity]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C3274648:Control [Qualitative Concept]
   711 E C0557651:Study [Manufactured Object]
   711 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "cohort studies separately."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0009247:Cohort Studies [Quantitative Concept]
   827   C0599755:Cohort [Population Group]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
Processing 00000000.tx.76: The case-control studies with incident dementia cases gave a pooled relative risk of 0.77 (95 percent CI: 0.61, 0.96), while the cohort studies gave a pooled relative risk estimate of 0.79 (95 percent CI: 0.61, 1.01). 

Phrase: "The case-control studies with incident dementia cases"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   800   C0007328:Case-Control Studies [Research Activity]
   770   C0872128:case control [Health Care Activity]
   767   C0085973:Case Studies [Intellectual Product]
   744   C0243148:control [Qualitative Concept]
   744   C0868928:Case [Functional Concept]
   744   C0947630:studies [Laboratory Procedure]
   744   C1550141:Control [Substance]
   744   C1706255:CASE [Medical Device]
   744   C1706256:Case [Conceptual Entity]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C3274648:Control [Qualitative Concept]
   711 E C0557651:Study [Manufactured Object]
   711 E C2603343:Study [Research Activity]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "a pooled relative risk of 0.77"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0242492:Relative Risk [Quantitative Concept]
   748   C0035647:Risk [Qualitative Concept]
   748   C0080103:Relative [Family Group]
   748   C0205345:Relative [Qualitative Concept]
   748   C1547039:*Relative [Quantitative Concept]

Phrase: "(95 percent CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.61,"

Phrase: "0.96"

Phrase: ")"

Phrase: ","

Phrase: "while"

Phrase: "the cohort studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0009247:Cohort Studies [Quantitative Concept]
   861   C0599755:Cohort [Population Group]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "a pooled relative risk estimate of 0.79"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0242492:Relative Risk [Quantitative Concept]
   770   C1519101:Risk Estimate [Quantitative Concept]
   744   C0035647:Risk [Qualitative Concept]
   744   C0080103:Relative [Family Group]
   744   C0205345:Relative [Qualitative Concept]
   744   C0750572:Estimate [Quantitative Concept]
   744   C1547039:*Relative [Quantitative Concept]

Phrase: "(95 percent CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.61,"

Phrase: "1.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.77: Finally, the results of the randomized clinical trials that evaluated the efficacy of an NSAID against placebo are presented in table 3. 

Phrase: "Finally,"

Phrase: "the results of the randomized clinical trials"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "that"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the efficacy of an NSAID"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0598333:drug efficacy [Qualitative Concept]
   742   C1280519:Efficacy [Qualitative Concept]
   742   C1707887:EFFICACY [Research Activity]

Phrase: "against placebo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032042:placebo [Therapeutic or Preventive Procedure]
  1000   C1696465:placebo [Biomedical or Dental Material]
  1000   C1706408:PLACEBO [Research Activity]

Phrase: "are"

Phrase: "presented in table 3."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C0449450:Presented [Idea or Concept]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.78: All trials included patients with Alzheimers disease or patients with probable Alzheimers disease. 

Phrase: "All trials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0008976:Trial [Research Activity]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "patients with Alzheimers disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030705:Patients [Patient or Disabled Group]

Phrase: "or"

Phrase: "patients with probable Alzheimers disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.79: None of the trials showed a statistically significant reduction in cognitive decline. 

Phrase: "None of the trials"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]
   737   C0008976:Trial [Research Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a statistically significant reduction in cognitive decline."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.80: View this table: [in this window] [in a new window]  TABLE 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.81: Summary results of placebo controlled trials of the use of nonsteroidal antiinflammatory drugs in Alzheimers disease   DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  The results of our study indicate that the benefit of NSAIDs in preventing dementia and cognitive impairment was 50 percent in studies with prevalent dementia cases, declined to 20 percent in studies with incident dementia cases, and was absent in studies where cognitive decline was used as the endpoint. 

Phrase: "Summary"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "results of placebo controlled trials of the use of nonsteroidal antiinflammatory drugs"
Meta Candidates (Total=29; Excluded=7; Pruned=0; Remaining=22)
   770   C0003211:Nonsteroidal Anti-inflammatory Drugs [Pharmacologic Substance]
   759 E C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   755   C0678297:controlled drug use [Individual Behavior]
   753   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   753   C1706408:placebo-controlled [Research Activity]
           PLACEBO
   751   C0304229:drugs trials [Pharmacologic Substance]
   751   C0360835:controlled drugs [Regulation or Law]
   751   C1524063:Use of [Functional Concept]
   736   C0013227:Drugs [Pharmacologic Substance]
   736   C0032042:placebo [Therapeutic or Preventive Procedure]
   736   C0042153:use [Functional Concept]
   736   C0457083:Use [Functional Concept]
   736   C1274040:Result [Functional Concept]
   736   C1515999:Anti-inflammatory [Qualitative Concept]
   736   C1546471:Result [Idea or Concept]
   736   C1696465:placebo [Biomedical or Dental Material]
   736   C1947944:Use [Intellectual Product]
   736   C2587213:Controlled [Functional Concept]
   736   C2825142:Result [Finding]
   734 E C0013168:control drugs [Governmental or Regulatory Activity]
   734   C0242510:drug use [Mental or Behavioral Dysfunction]
   703   C0008976:Trial [Research Activity]
   703 E C0243148:control [Qualitative Concept]
   703 E C1254351:Drug [Pharmacologic Substance]
   703 E C1550141:Control [Substance]
   703 E C1882979:Control [Conceptual Entity]
   703 E C3274648:Control [Qualitative Concept]

Phrase: "in Alzheimers disease   DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The results of our study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0683954:results study [Finding]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the benefit of NSAIDs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0814225:Benefit [Quantitative Concept]

Phrase: "in preventing dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "cognitive impairment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0338656:Cognitive impairment [Mental or Behavioral Dysfunction]
   861   C0684336:Impairment [Pathologic Function]

Phrase: "was"

Phrase: "50 percent in studies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439165:Percent [Quantitative Concept]

Phrase: "with prevalent dementia cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "declined to 20 percent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439165:Percent [Quantitative Concept]

Phrase: "in studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "with incident dementia cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "was"

Phrase: "absent in studies where cognitive decline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:Absent [Quantitative Concept]
   753   C2699517:ABSENT [Finding]

Phrase: "was"

Phrase: "used as the endpoint."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C1273517:used [Finding]
   770   C2349179:End Point [Qualitative Concept]
   770   C2826544:ENDPOINT [Quantitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.82: There are at least three forms of bias that could explain why the benefit from NSAIDs was larger in studies with prevalent cases than in studies with incident cases: recall bias, prescription bias, and publication bias. 

Phrase: "There"

Phrase: "are at least three forms of bias"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   748   C0205449:Three [Quantitative Concept]
   748   C0242568:Bias [Idea or Concept]
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   748   C1504315:Bias [Bird]
   748   C1551058:Are [Quantitative Concept]
   714 E C1061346:Bia [Eukaryote]
   714 E C1522492:Form [Functional Concept]
   714 E C1704746:BIA [Diagnostic Procedure]

Phrase: "that"

Phrase: "could"

Phrase: "explain"

Phrase: "why"

Phrase: "the benefit from NSAIDs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0814225:Benefit [Quantitative Concept]

Phrase: "was"

Phrase: "larger in studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0443228:larger [Quantitative Concept]
   790   C0549177:Larger [Quantitative Concept]
   790   C1704243:Larger [Quantitative Concept]

Phrase: "with prevalent cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "than"

Phrase: "in studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "with incident cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   861   C1551358:incident [Idea or Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: ":"

Phrase: "recall bias,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0242568:Bias [Idea or Concept]
   861   C1504315:Bias [Bird]
   827 E C1061346:Bia [Eukaryote]
   827 E C1704746:BIA [Diagnostic Procedure]

Phrase: "prescription bias,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0242568:Bias [Idea or Concept]
   861   C1504315:Bias [Bird]
   827 E C1061346:Bia [Eukaryote]
   827 E C1704746:BIA [Diagnostic Procedure]

Phrase: "and"

Phrase: "publication bias."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0206086:Publication Bias [Qualitative Concept]
   861   C0242568:Bias [Idea or Concept]
   861   C1504315:Bias [Bird]
   827 E C1061346:Bia [Eukaryote]
   827 E C1704746:BIA [Diagnostic Procedure]
Processing 00000000.tx.83: First, subjects from studies with prevalent cases have impaired memory at the time of study, which makes data collection between cases and controls likely to be different, resulting in recall bias. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "subjects from studies"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   841   C0681850:Study Subject [Group]
           Subject
   790   C0947630:studies [Laboratory Procedure]
   790   C1550501:{Subject} [Idea or Concept]
   790   C1706203:Subject [Idea or Concept]
   790   C2349001:Subject [Human]
   790   C2697811:Subject [Functional Concept]
   756 E C0557651:Study [Manufactured Object]
   756 E C2603343:Study [Research Activity]

Phrase: "with prevalent cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "have"

Phrase: "impaired memory at the time of study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0233794:Impaired memory [Mental or Behavioral Dysfunction]
   748   C0025260:Memory [Mental Process]
   748   C0700327:memory [Finding]
   748   C1706377:Memory [Manufactured Object]

Phrase: "which"

Phrase: "makes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "data collection between cases"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0010995:Data Collection [Research Activity]
   770   C1511726:Data [Idea or Concept]
   770   C1516698:Collection [Functional Concept]
   770   C1704814:Collection [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "different,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1705242:Different [Qualitative Concept]
   928 E C1705241:*Difference [Quantitative Concept]
   900 E C0443199:Differential [Qualitative Concept]

Phrase: "resulting in recall bias."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   833   C0332294:Resulting in [Functional Concept]
   770   C0034770:Recall [Mental Process]
   770   C0242568:Bias [Idea or Concept]
   770   C0678226:resulting [Functional Concept]
   770   C1504315:Bias [Bird]
   770   C1705180:Recall [Governmental or Regulatory Activity]
   770   C2361119:Recall [Clinical Attribute]
   737 E C1061346:Bia [Eukaryote]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C1704746:BIA [Diagnostic Procedure]
   737 E C2825142:Result [Finding]
Processing 00000000.tx.84: Second, prescription bias occurs more frequently in studies with prevalent cases because demented patients have a reduced perception of pain (38, 39), possibly leading to a reduced use of NSAIDs. 

Phrase: "Second, prescription bias"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0242568:Bias [Idea or Concept]
   827   C1504315:Bias [Bird]
   793 E C1061346:Bia [Eukaryote]
   793 E C1704746:BIA [Diagnostic Procedure]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "more frequently in studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0205172:More [Functional Concept]
   770   C0332183:Frequently [Temporal Concept]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "with prevalent cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "because"

Phrase: "demented patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "have"

Phrase: "a reduced perception of pain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   862   C0234194:perception of pain [Organism Function,Organ or Tissue Function]
           Pain Perception
   760   C0030971:Perception [Mental Process]

Phrase: "(38,"

Phrase: "39"

Phrase: ")"

Phrase: ","

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "leading to a reduced use of NSAIDs."
Meta Candidates (Total=19; Excluded=6; Pruned=0; Remaining=13)
   790   C0003211:Nonsteroidal Anti-inflammatory Drugs [Pharmacologic Substance]
   779 E C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   764   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   764   C1524063:Use of [Functional Concept]
   745   C0242510:drug use [Mental or Behavioral Dysfunction]
   742   C0013227:Drugs [Pharmacologic Substance]
   742   C0042153:use [Functional Concept]
   742   C0332152:Leading [Temporal Concept]
   742   C0392756:Reduced [Qualitative Concept]
   742   C0457083:Use [Functional Concept]
   742   C1515999:Anti-inflammatory [Qualitative Concept]
   742   C1522538:Leading [Functional Concept]
   742   C1947944:Use [Intellectual Product]
   708 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   708 E C1254351:Drug [Pharmacologic Substance]
   708 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   708 E C2348269:Lead [Element, Ion, or Isotope]
   708 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.85: Moreover, because of the adverse effects of NSAIDs, physicians might be less inclined to prescribe NSAIDs to demented subjects. 

Phrase: "Moreover,"

Phrase: "because of the adverse effects"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0001688:adverse effects [Functional Concept]
  1000   C0879626:Adverse effects [Pathologic Function]
   966 E C0559546:Adverse Effect [Finding]
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "of NSAIDs,"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0003211:Nonsteroidal Anti-inflammatory Drugs [Pharmacologic Substance]
   988 E C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   901   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   827   C0013227:Drugs [Pharmacologic Substance]
   827   C1515999:Anti-inflammatory [Qualitative Concept]
   793 E C1254351:Drug [Pharmacologic Substance]
   755 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   755 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   727 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "physicians"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0031831:Physicians [Professional or Occupational Group]
   966 E C0804815:Physician [Clinical Attribute]

Phrase: "might"

Phrase: "be"

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "inclined"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prescribe"

Phrase: "NSAIDs to demented subjects."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0003211:Nonsteroidal Anti-inflammatory Drugs [Pharmacologic Substance]
   822 E C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   790   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   753   C0013227:Drugs [Pharmacologic Substance]
   753   C1515999:Anti-inflammatory [Qualitative Concept]
   719 E C1254351:Drug [Pharmacologic Substance]
Processing 00000000.tx.86: Hence, in the studies with prevalent cases, the reduced intake of NSAIDs might be more the consequence of the dementia than the cause. 

Phrase: "Hence,"

Phrase: "in the studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "with prevalent cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "the reduced intake of NSAIDs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1512806:Intake [Functional Concept]

Phrase: "might"

Phrase: "be"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "the consequence of the dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "than the cause."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.87: Third, it is apparent from the funnel plot that the studies with prevalent cases are more heterogeneous and more skewed to the left than the follow-up studies, resulting in larger pooled estimates of benefit of NSAID use in these studies. 

Phrase: "Third,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "it"

Phrase: "is"

Phrase: "apparent from the funnel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0750489:apparent [Idea or Concept]

Phrase: "plot"

Phrase: "that"

Phrase: "the studies with prevalent cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   781   C0085973:Case Studies [Intellectual Product]
   762   C0033106:Prevalence Studies [Quantitative Concept]
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "more heterogeneous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019409:Heterogeneous [Qualitative Concept]

Phrase: "and"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "skewed to the left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205091:Left [Spatial Concept]
   770   C1552822:left [Functional Concept]

Phrase: "than the follow-up studies,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0016441:Follow-Up Studies [Research Activity]
   901   C0589120:Follow-up [Finding]
   901   C1522577:follow-up [Health Care Activity]
   901   C1704685:FOLLOW-UP [Intellectual Product]
   901   C3274571:FOLLOW-UP [Health Care Activity]
   827   C0332283:follow [Temporal Concept]
   827   C0947630:studies [Laboratory Procedure]
   827   C1719822:Follow [Intellectual Product]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "resulting in larger pooled estimates of benefit"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   778   C0332294:Resulting in [Functional Concept]
   748   C0443228:larger [Quantitative Concept]
   748   C0549177:Larger [Quantitative Concept]
   748   C0678226:resulting [Functional Concept]
   748   C0750572:estimates [Quantitative Concept]
   748   C0814225:Benefit [Quantitative Concept]
   748   C1704243:Larger [Quantitative Concept]
   748   C1709595:Pooled [Conceptual Entity]
   748   C2349200:Pooled [Functional Concept]
   714 E C0337051:Pool [Geographic Area]
   714 E C1274040:Result [Functional Concept]
   714 E C1509144:pool [Clinical Attribute]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]

Phrase: "of NSAID use"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   840   C0281991:Steroid Use [Individual Behavior]
   827   C0242510:drug use [Mental or Behavioral Dysfunction]
   799   C0042153:use [Functional Concept]
   799   C0457083:Use [Functional Concept]
   799   C1947944:Use [Intellectual Product]
   780   C0003211:Non-steroidal anti-inflammatory drug [Pharmacologic Substance]
   780   C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   706   C0003212:steroidal anti-inflammatory drugs [Pharmacologic Substance,Steroid]

Phrase: "in these studies."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]
Processing 00000000.tx.88: We found no difference in relative risk between the case-control studies with incident dementia cases and cohort studies, although the potential for recall bias in case-control studies is theoretically higher. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no difference in relative risk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "between the case-control studies"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
  1000   C0007328:Case-Control Studies [Research Activity]
   913   C0085973:Case Studies [Intellectual Product]
   901   C0872128:case control [Health Care Activity]
   827   C0243148:control [Qualitative Concept]
   827   C0868928:Case [Functional Concept]
   827   C0947630:studies [Laboratory Procedure]
   827   C1550141:Control [Substance]
   827   C1706255:CASE [Medical Device]
   827   C1706256:Case [Conceptual Entity]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "with incident dementia cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "cohort studies,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0009247:Cohort Studies [Quantitative Concept]
   861   C0599755:Cohort [Population Group]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "although"

Phrase: "the potential for recall bias"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3245505:Potential [Qualitative Concept]

Phrase: "in case-control studies"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
  1000   C0007328:Case-Control Studies [Research Activity]
   913   C0085973:Case Studies [Intellectual Product]
   901   C0872128:case control [Health Care Activity]
   827   C0243148:control [Qualitative Concept]
   827   C0868928:Case [Functional Concept]
   827   C0947630:studies [Laboratory Procedure]
   827   C1550141:Control [Substance]
   827   C1706255:CASE [Medical Device]
   827   C1706256:Case [Conceptual Entity]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "theoretically higher."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]
   777 E C0489786:Height [Organism Attribute]
Processing 00000000.tx.89: However, a total number of 10 studies to investigate the presence of recall bias is rather small. 

Phrase: "However,"

Phrase: "a total number of 10"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0237753:*Number [Quantitative Concept]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the presence of recall bias"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "rather small."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0700321:Small [Quantitative Concept]
Processing 00000000.tx.90: Therefore, the interpretation of the absence of a significant difference between the two types of design with incident dementia cases should be interpreted with caution. 

Phrase: "Therefore,"

Phrase: "the interpretation of the absence of a significant difference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0459471:Interpretation [Intellectual Product]
   742   C3173575:Interpretation [Clinical Attribute]

Phrase: "between the two types"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332307:Types [Qualitative Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "of design"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1707689:Design [Activity]
  1000   C2983265:DESIGN [Intellectual Product]

Phrase: "with incident dementia cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "should"

Phrase: "be"

Phrase: "interpreted with caution."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1285553:interpreted [Functional Concept]
Processing 00000000.tx.91: There were 10 studies with incident cases of dementia. 

Phrase: "There"

Phrase: "were"

Phrase: "10 studies with incident cases of dementia."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   757   C0085973:Case Studies [Intellectual Product]
   748   C0947630:studies [Laboratory Procedure]
   714 E C0557651:Study [Manufactured Object]
   714 E C2603343:Study [Research Activity]
Processing 00000000.tx.92: Within these 10 studies, there were four case-control studies with incident dementia cases and six cohort studies. 

Phrase: "Within these 10 studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "there"

Phrase: "were"

Phrase: "four case-control studies with incident dementia cases"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   800   C0007328:Case-Control Studies [Research Activity]
   770   C0872128:case control [Health Care Activity]
   767   C0085973:Case Studies [Intellectual Product]
   744   C0243148:control [Qualitative Concept]
   744   C0868928:Case [Functional Concept]
   744   C0947630:studies [Laboratory Procedure]
   744   C1550141:Control [Substance]
   744   C1706255:CASE [Medical Device]
   744   C1706256:Case [Conceptual Entity]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C3274648:Control [Qualitative Concept]
   711 E C0557651:Study [Manufactured Object]
   711 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "six cohort studies."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0009247:Cohort Studies [Quantitative Concept]
   827   C0599755:Cohort [Population Group]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
Processing 00000000.tx.93: Both types of study gave a similar pooled estimate of relative risk. 

Phrase: "Both types of study"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   802   C0035171:Study Type [Research Activity]
   802   C2985227:Study Type [Research Activity]
   770   C0332307:Types [Qualitative Concept]
   737 E C1547052:*Type [Quantitative Concept]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "a similar pooled estimate of relative risk."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1519101:Risk Estimate [Quantitative Concept]
   748   C0750572:Estimate [Quantitative Concept]
Processing 00000000.tx.94: If recall bias was a major form of bias, the relative risk of the case-control studies should have been smaller. 

Phrase: "If"

Phrase: "recall bias"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0242568:Bias [Idea or Concept]
   861   C1504315:Bias [Bird]
   827 E C1061346:Bia [Eukaryote]
   827 E C1704746:BIA [Diagnostic Procedure]

Phrase: "was"

Phrase: "a major form of bias,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]

Phrase: "the relative risk of the case-control studies"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0242492:Relative Risk [Quantitative Concept]
   767   C1321115:control risk [Individual Behavior]
   744   C0035647:Risk [Qualitative Concept]
   744   C0080103:Relative [Family Group]
   744   C0205345:Relative [Qualitative Concept]
   744   C1547039:*Relative [Quantitative Concept]

Phrase: "should"

Phrase: "have"

Phrase: "been"

Phrase: "smaller."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0547044:Smaller [Qualitative Concept]
  1000   C0700321:Smaller [Quantitative Concept]
Processing 00000000.tx.95: However, because of the wide confidence intervals around both estimates (because of the small number of studies), it is difficult to ascertain whether the studies truly had equal estimates. 

Phrase: "However,"

Phrase: "because of the wide confidence intervals"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   901   C0009667:Confidence Intervals [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:intervals [Temporal Concept]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   793 E C1552654:Interval [Idea or Concept]
   793 E C1552713:Interval [Intellectual Product]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "around both estimates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:estimates [Quantitative Concept]

Phrase: "("

Phrase: "because of the small number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "of studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "ascertain"

Phrase: "whether"

Phrase: "the studies truly"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "had"

Phrase: "equal estimates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750572:estimates [Quantitative Concept]
Processing 00000000.tx.96: There was a significant association between NSAID use and studies with incident cases of dementia, while there was no significant association in studies where cognitive decline was used as the outcome. 

Phrase: "There"

Phrase: "was"

Phrase: "a significant association between NSAID use"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0004083:Association [Mental Process]
   739   C0439849:Association [Qualitative Concept]
   739   C0596306:Association [Phenomenon or Process]
   739   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "studies with incident cases of dementia,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   767   C0085973:Case Studies [Intellectual Product]
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]
   753   C0557651:Study [Manufactured Object]
   753   C0868928:Cases [Functional Concept]
   753   C0947630:studies [Laboratory Procedure]
   753   C1533148:Cases [Quantitative Concept]
   753   C1551358:incident [Idea or Concept]
   753   C2603343:Study [Research Activity]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]

Phrase: "while"

Phrase: "there"

Phrase: "was"

Phrase: "no significant association in studies where cognitive decline"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "used as the outcome."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1273517:used [Finding]
   770   C1274040:Outcome [Functional Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.97: Prescription bias might also be the cause of this difference. 

Phrase: "Prescription bias"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0242568:Bias [Idea or Concept]
   861   C1504315:Bias [Bird]
   827 E C1061346:Bia [Eukaryote]
   827 E C1704746:BIA [Diagnostic Procedure]

Phrase: "might"

Phrase: "also"

Phrase: "be"

Phrase: "the cause of this difference."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015127:cause [Functional Concept]
   760   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.98: Incident subjects with cognitive decline will be relatively free from cognitive dysfunction at baseline, while incident cases with dementia are in a relatively later stage of the disease. 

Phrase: "Incident subjects with cognitive decline"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "will"

Phrase: "be"

Phrase: "relatively free from cognitive dysfunction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332296:free [Functional Concept]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]

Phrase: "at baseline,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0168634:baseline [Biomedical or Dental Material]
  1000   C1442488:Baseline [Quantitative Concept]

Phrase: "while"

Phrase: "incident cases with dementia"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   770   C1551358:incident [Idea or Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "are in a relatively later"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1551058:Are [Quantitative Concept]
   726   C0205087:Late [Temporal Concept]

Phrase: "stage of the disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   819   C0699749:disease stage [Diagnostic Procedure]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0205390:Stage [Temporal Concept]
   770   C1300072:Stage [Clinical Attribute]
   770   C1306673:Stage [Qualitative Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.99: In the earlier stages of the disease, prescription bias might not be present. 

Phrase: "In the earlier stages"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C2363430:early stages [Temporal Concept]
   966 E C1517886:Early Stage [Classification]
   861   C1306673:Stages [Qualitative Concept]
   827 E C0205390:Stage [Temporal Concept]
   827 E C1300072:Stage [Clinical Attribute]

Phrase: "of the disease,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "prescription bias"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0242568:Bias [Idea or Concept]
   861   C1504315:Bias [Bird]
   827 E C1061346:Bia [Eukaryote]
   827 E C1704746:BIA [Diagnostic Procedure]

Phrase: "might"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "present."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]
Processing 00000000.tx.100: To explore whether prescription bias is the cause of the observed association between NSAID use and Alzheimers disease or whether there is a true beneficial effect, we decided upon randomized clinical trials whose patients were without early signs of Alzheimers disease (40). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "explore"

Phrase: "whether"

Phrase: "prescription bias"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0242568:Bias [Idea or Concept]
   861   C1504315:Bias [Bird]
   827 E C1061346:Bia [Eukaryote]
   827 E C1704746:BIA [Diagnostic Procedure]

Phrase: "is"

Phrase: "the cause of the observed association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015127:cause [Functional Concept]
   753   C1524003:Cause [Conceptual Entity]

Phrase: "between NSAID use"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   840   C0281991:Steroid Use [Individual Behavior]
   827   C0242510:drug use [Mental or Behavioral Dysfunction]
   799   C0042153:use [Functional Concept]
   799   C0457083:Use [Functional Concept]
   799   C1947944:Use [Intellectual Product]
   780   C0003211:Non-steroidal anti-inflammatory drug [Pharmacologic Substance]
   780   C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   706   C0003212:steroidal anti-inflammatory drugs [Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "or"

Phrase: "whether"

Phrase: "there"

Phrase: "is"

Phrase: "a true beneficial effect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]

Phrase: "we"

Phrase: "decided upon randomized clinical trials"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0206034:Clinical Trials, Randomized [Intellectual Product,Research Activity]
   806   C0008976:Clinical Trials [Research Activity]
           Trial
   806   C1096775:clinical trials [Intellectual Product]
   760   C0034656:randomized [Research Activity]
   760   C0205210:Clinical [Qualitative Concept]

Phrase: "whose patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "were without early signs of Alzheimers disease"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0002395:Alzheimers disease [Disease or Syndrome]
   774   C0679245:early disease [Temporal Concept]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0220912:signs [Functional Concept]
   748   C0220913:signs [Manufactured Object]
   748   C0311392:SIGNS [Finding]
   748   C1279919:Early [Temporal Concept]
   714 E C1547188:Sign [Idea or Concept]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.101: If the period between NSAID use and disease onset is relatively short, then it is difficult to differentiate between cause and effect. 

Phrase: "If"

Phrase: "the period between NSAID use"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0439531:/period [Temporal Concept]
   742   C1948053:Period [Temporal Concept]

Phrase: "and"

Phrase: "disease onset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0277793:disease onset [Temporal Concept]
   861   C0332162:Onset [Qualitative Concept]

Phrase: "is"

Phrase: "relatively short, then"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1282927:short [Qualitative Concept]
   827   C1806781:Short [Quantitative Concept]
   827   C1883708:Then [Temporal Concept]
   827   C2350002:Short [Quantitative Concept]

Phrase: "it"

Phrase: "is"

Phrase: "difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "differentiate between cause"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0015127:cause [Functional Concept]
   790   C0205615:differentiate [Qualitative Concept]
   790   C1524003:Cause [Conceptual Entity]

Phrase: "and"

Phrase: "effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.102: With a short period between exposure and outcome, reduced intake of NSAIDs among subjects with dementia could also be the consequence of the disease. 

Phrase: "With a short period"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0425946:short period [Finding]
   861   C0439531:/period [Temporal Concept]
   861   C1948053:Period [Temporal Concept]
   789 E C0332182:Periodic [Temporal Concept]
   789 E C1706381:PERIODIC [Intellectual Product]
   761 E C0031084:Periodicities [Temporal Concept]

Phrase: "between exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]

Phrase: "and"

Phrase: "outcome,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1274040:Outcome [Functional Concept]

Phrase: "reduced intake of NSAIDs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1512806:Intake [Functional Concept]

Phrase: "among subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "with dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "could"

Phrase: "also"

Phrase: "be"

Phrase: "the consequence of the disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0686907:Consequence of [Functional Concept]
           Consequence
Processing 00000000.tx.103: Four studies (14, 16, 20, 26) tried to avoid this bias by evaluating the use of acetaminophen, to control for differing patterns of drug use between demented and nondemented subjects. 

Phrase: "Four studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "(14,"

Phrase: "16,"

Phrase: "20,"

Phrase: "26"

Phrase: ")"

Phrase: "tried"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "avoid"

Phrase: "this bias by evaluating"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0242568:Bias [Idea or Concept]
   770   C1504315:Bias [Bird]
   737 E C1061346:Bia [Eukaryote]
   737 E C1704746:BIA [Diagnostic Procedure]

Phrase: "the use of acetaminophen,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1524063:Use of [Functional Concept]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "control for differing patterns of drug use"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   778   C0242510:drug use [Mental or Behavioral Dysfunction]
   774   C0013168:Drug Control [Governmental or Regulatory Activity]
   774   C1524063:Use of [Functional Concept]
   748   C0013227:Drug [Pharmacologic Substance]
   748   C0042153:use [Functional Concept]
   748   C0243148:control [Qualitative Concept]
   748   C0449774:Patterns [Spatial Concept]
   748   C0457083:Use [Functional Concept]
   748   C1254351:Drug [Pharmacologic Substance]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C1947944:Use [Intellectual Product]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "between demented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0860630:demented [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "nondemented subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]
Processing 00000000.tx.104: Many authors argued that, because the demented and nondemented subjects did not differ in their acetaminophen use but did vary in their NSAID use, NSAIDs must be associated with better cognitive function. 

Phrase: "Many authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "argued"

Phrase: "that,"

Phrase: "because"

Phrase: "the demented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0860630:demented [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "nondemented subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differ in their acetaminophen use"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0000970:Acetaminophen [Organic Chemical,Pharmacologic Substance]
   760   C0042153:use [Functional Concept]
   760   C0457083:Use [Functional Concept]
   760   C1947944:Use [Intellectual Product]
   760   C2917659:Acetaminophen [Pharmacologic Substance]
   704 E C0307802:Tempra [Organic Chemical,Pharmacologic Substance]
   704 E C0699142:Tylenol [Organic Chemical,Pharmacologic Substance]

Phrase: "but"

Phrase: "did"

Phrase: "vary in their NSAID use,"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   849   C0003211:Non-steroidal anti-inflammatory drug [Pharmacologic Substance]
   849   C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   790   C0003209:anti inflammatory drug [Pharmacologic Substance]
           Anti-inflammatory
   790   C0003212:steroidal anti-inflammatory drugs [Pharmacologic Substance,Steroid]
   764   C0242510:drug use [Mental or Behavioral Dysfunction]
   764   C1515999:Anti-inflammatory [Qualitative Concept]
   742   C0013227:Drug [Pharmacologic Substance]
   742   C0042153:use [Functional Concept]
   742   C0333348:Inflammatory [Functional Concept]
   742   C0457083:Use [Functional Concept]
   742   C1254351:Drug [Pharmacologic Substance]
   742   C1518422:Non [Functional Concept]
   742   C1947944:Use [Intellectual Product]
   726   C0260264:drug steroid [Steroid]
   726   C0281991:Steroid Use [Individual Behavior]

Phrase: "NSAIDs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0003211:Nonsteroidal Anti-inflammatory Drugs [Pharmacologic Substance]
   988 E C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   901   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   827   C0013227:Drugs [Pharmacologic Substance]
   827   C1515999:Anti-inflammatory [Qualitative Concept]
   793 E C1254351:Drug [Pharmacologic Substance]
   755 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   755 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   727 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "must"

Phrase: "be"

Phrase: "associated with better cognitive function."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0392335:cognitive function [Mental Process]
   797   C1292719:Associated function [Functional Concept]
   760   C0031843:function [Physiologic Function]
   760   C0332272:Better [Qualitative Concept]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1516691:Cognitive [Functional Concept]
   760   C1705273:Function [Intellectual Product]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.105: We think, however, that, in demented patients who might report less pain than nondemented subjects, NSAIDs are the first drugs to be prescribed less frequently. 

Phrase: "We"

Phrase: "think"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:think [Mental Process]

Phrase: ","

Phrase: "however,"

Phrase: "that,"

Phrase: "in demented patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "who"

Phrase: "might"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "less pain than nondemented subjects,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0030193:Pain [Sign or Symptom]
   760   C1962977:Pain NOS [Finding]

Phrase: "NSAIDs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0003211:Nonsteroidal Anti-inflammatory Drugs [Pharmacologic Substance]
   988 E C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   901   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   827   C0013227:Drugs [Pharmacologic Substance]
   827   C1515999:Anti-inflammatory [Qualitative Concept]
   793 E C1254351:Drug [Pharmacologic Substance]
   755 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   755 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   727 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "are"

Phrase: "the first drugs to"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   827   C0013227:Drugs [Pharmacologic Substance]
   793 E C1254351:Drug [Pharmacologic Substance]
   755 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   755 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   727 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "be"

Phrase: "prescribed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0278329:Prescribed [Health Care Activity]

Phrase: "less frequently."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332183:Frequently [Temporal Concept]
   861   C0439092:less [Intellectual Product]
   861   C0547044:Less [Qualitative Concept]
Processing 00000000.tx.106: This means that studies with prevalent cases are more likely to suffer from prescription bias than studies with incident cases. 

Phrase: "This means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "that"

Phrase: "studies with prevalent cases"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   802   C0085973:Case Studies [Intellectual Product]
   783   C0033106:Prevalence Studies [Quantitative Concept]
   770   C0557651:Study [Manufactured Object]
   770   C0868928:Cases [Functional Concept]
   770   C0947630:studies [Laboratory Procedure]
   770   C1533148:Cases [Quantitative Concept]
   770   C2603343:Study [Research Activity]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "are"

Phrase: "more likely to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205172:More [Functional Concept]
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]

Phrase: "suffer from prescription bias"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0033080:Prescription [Health Care Activity]
   770   C0242568:Bias [Idea or Concept]
   770   C0683278:suffer [Mental or Behavioral Dysfunction]
   770   C1504315:Bias [Bird]
   770   C1521941:Prescription [Intellectual Product]
   737 E C1061346:Bia [Eukaryote]
   737 E C1704746:BIA [Diagnostic Procedure]

Phrase: "than"

Phrase: "studies with incident cases."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   802   C0085973:Case Studies [Intellectual Product]
   770   C0557651:Study [Manufactured Object]
   770   C0868928:Cases [Functional Concept]
   770   C0947630:studies [Laboratory Procedure]
   770   C1533148:Cases [Quantitative Concept]
   770   C1551358:incident [Idea or Concept]
   770   C2603343:Study [Research Activity]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.107: Because Alzheimers disease, the most common dementia, has an insidious onset, it is also important to know what the different studies used as the index date. 

Phrase: "Because"

Phrase: "Alzheimers disease,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "the most common dementia,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "has"

Phrase: "an insidious onset,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1298634:Insidious onset [Qualitative Concept]
   861   C0332162:Onset [Qualitative Concept]

Phrase: "it"

Phrase: "is"

Phrase: "also important to"

Phrase: "know"

Phrase: "what the different studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "used as the index date."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0011008:Date [Temporal Concept]
   760   C0918012:Index [Intellectual Product]
   760   C1273517:used [Finding]
   760   C1552854:index [Idea or Concept]
   760   C1637833:% index [Quantitative Concept]
   760   C2348077:Date [Food]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.108: All studies with prevalent cases took the date of diagnosis of dementia, while three studies with incident dementia cases took the date of first symptoms of disease (17, 21, 24), and seven studies with incident dementia cases used the date of diagnosis of dementia. 

Phrase: "All"

Phrase: "studies with prevalent cases"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   802   C0085973:Case Studies [Intellectual Product]
   783   C0033106:Prevalence Studies [Quantitative Concept]
   770   C0557651:Study [Manufactured Object]
   770   C0868928:Cases [Functional Concept]
   770   C0947630:studies [Laboratory Procedure]
   770   C1533148:Cases [Quantitative Concept]
   770   C2603343:Study [Research Activity]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "took"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515187:Take [Health Care Activity]

Phrase: "the date of diagnosis of dementia,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C2316983:Date of diagnosis [Temporal Concept]
   753   C0011008:Date [Temporal Concept]
   753   C2348077:Date [Food]

Phrase: "while"

Phrase: "three studies with incident dementia cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   767   C0085973:Case Studies [Intellectual Product]
   753   C0947630:studies [Laboratory Procedure]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]

Phrase: "took"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515187:Take [Health Care Activity]

Phrase: "the date of first symptoms of disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0011008:Date [Temporal Concept]
   748   C2348077:Date [Food]

Phrase: "(17,"

Phrase: "21,"

Phrase: "24"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "seven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205453:Seven [Quantitative Concept]

Phrase: "studies with incident dementia cases"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   781   C0085973:Case Studies [Intellectual Product]
   760   C0011265:dementia [Mental or Behavioral Dysfunction]
   760   C0497327:Dementia [Mental or Behavioral Dysfunction]
   760   C0557651:Study [Manufactured Object]
   760   C0868928:Cases [Functional Concept]
   760   C0947630:studies [Laboratory Procedure]
   760   C1533148:Cases [Quantitative Concept]
   760   C1551358:incident [Idea or Concept]
   760   C2603343:Study [Research Activity]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the date of diagnosis of dementia."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C2316983:Date of diagnosis [Temporal Concept]
   753   C0011008:Date [Temporal Concept]
   753   C2348077:Date [Food]
Processing 00000000.tx.109: The three studies where the date of onset of symptoms was used had similar relative risk estimates as the seven studies where the date of diagnosis was used. 

Phrase: "The three studies where"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "the date of onset of symptoms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0574845:Date of onset [Finding]
           Onset Date
   753   C0011008:Date [Temporal Concept]
   753   C2348077:Date [Food]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "had"

Phrase: "similar relative risk estimates as the seven studies where"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C0242492:Relative Risk [Quantitative Concept]
   742   C0035647:Risk [Qualitative Concept]
   742   C0080103:Relative [Family Group]
   742   C0205345:Relative [Qualitative Concept]
   742   C0750572:estimates [Quantitative Concept]
   742   C1547039:*Relative [Quantitative Concept]
   731   C1519101:Risk Estimate [Quantitative Concept]

Phrase: "the date of diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C2316983:Date of diagnosis [Temporal Concept]
   770   C0011008:Date [Temporal Concept]
   770   C2348077:Date [Food]

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.110: Some publications used in this meta-analysis originate from one cohort. 

Phrase: "Some publications"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0034036:Publications [Intellectual Product,Manufactured Object]
   966 E C0034037:Publication [Occupational Activity]
   966 E C1704324:Publication [Intellectual Product]

Phrase: "used in this meta-analysis"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0282458:Meta-Analysis [Intellectual Product]
   806   C0920317:Meta-Analysis [Research Activity]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1042496:Meta [Eukaryote]
   760   C1273517:used [Finding]
   760   C1524024:analysis [Functional Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "originate from one cohort."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205447:One [Quantitative Concept]
   770   C0599755:Cohort [Population Group]
Processing 00000000.tx.111: For example, the Canadian Study of Health and Aging and the Rotterdam Study both contributed two publications. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "the Canadian"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238884:CANADIAN [Finding]

Phrase: "Study of Health"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0018684:Health [Idea or Concept]
   790   C0557651:Study [Manufactured Object]
   790   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "Aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "and"

Phrase: "the Rotterdam Study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "both contributed two publications."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0034036:Publications [Intellectual Product,Manufactured Object]
   793 E C0034037:Publication [Occupational Activity]
   793 E C1704324:Publication [Intellectual Product]
Processing 00000000.tx.112: However, in both cases, one publication addressed the association in the prevalent dementia cases and the other publication addressed the association in the incident dementia cases. 

Phrase: "However,"

Phrase: "in both cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "one publication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034036:Publication [Intellectual Product,Manufactured Object]
   861   C0034037:Publication [Occupational Activity]
   861   C1704324:Publication [Intellectual Product]

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "the association in the prevalent dementia cases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "the other publication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034036:Publication [Intellectual Product,Manufactured Object]
  1000   C0034037:Publication [Occupational Activity]
  1000   C1704324:Publication [Intellectual Product]

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "the association in the incident dementia cases."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]
Processing 00000000.tx.113: Hence, we decided to include both articles in our analyses. 

Phrase: "Hence,"

Phrase: "we"

Phrase: "decided"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "both articles in our analyses."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1706852:Article [Intellectual Product]
Processing 00000000.tx.114: Moreover, the study named Established Populations for Epidemiologic Studies of the Elderly consists of four cohorts. 

Phrase: "Moreover,"

Phrase: "the study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "named"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027365:named [Intellectual Product]
   966 E C1547383:Name [Intellectual Product]

Phrase: "Established Populations for Epidemiologic Studies of the Elderly"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   767   C0681876:population studies [Research Activity]
   750 E C2348561:Study Population [Population Group]
   744   C0032659:Population [Quantitative Concept]
   744   C1257890:Population [Population Group]

Phrase: "consists of four cohorts."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205450:Four [Quantitative Concept]
   770   C0332529:CONSIST [Qualitative Concept]
   770   C0599755:cohorts [Population Group]
Processing 00000000.tx.115: In our analyses, we used estimates reported from the separate cohorts. 

Phrase: "In our analyses,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "estimates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:estimates [Quantitative Concept]

Phrase: "reported from the separate cohorts."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0443299:Separate [Spatial Concept]
   760   C0599755:cohorts [Population Group]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.116: The study reported by Saag et al. 

Phrase: "The study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "reported by Saag et al."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C1709908:Reported By [Group]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.117: (27) uses data from the Iowa cohort, while Hanlon et al. 

Phrase: "(27"

Phrase: ")"

Phrase: "uses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "data from the Iowa cohort,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]

Phrase: "while"

Phrase: "Hanlon et al."
Processing 00000000.tx.118: (28) use data from the Duke cohort. 

Phrase: "(28"

Phrase: ")"

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "data from the Duke cohort."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]
Processing 00000000.tx.119: The study reported by Rozzini et al. 

Phrase: "The study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "reported by Rozzini et al."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C1709908:Reported By [Group]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.120: (5) uses data from the East Boston, Massachusetts, New Haven, Connecticut, and Iowa cohorts. 

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "uses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "data from the East Boston,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]

Phrase: "Massachusetts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024874:Massachusetts [Geographic Area]

Phrase: "New Haven,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205314:New [Temporal Concept]

Phrase: "Connecticut,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009778:Connecticut [Geographic Area]

Phrase: "and"

Phrase: "Iowa cohorts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0599755:cohorts [Population Group]
Processing 00000000.tx.121: In discussing their results, Rozzini et al. indicate that the study by Saag et al. is "substantially different in measure of cognitive functioning and analytical approach, ... making comparability between that study and our study problematic" (5, p. 1029). 

Phrase: "In discussing"

Phrase: "their results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "Rozzini et al."

Phrase: "indicate"

Phrase: "that"

Phrase: "the study by Saag et al. is """
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0557651:Study [Manufactured Object]
   748   C2603343:Study [Research Activity]

Phrase: "substantially different in measure of cognitive functioning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "analytical approach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449445:Approach [Spatial Concept]

Phrase: "... making comparability between"

Phrase: "that study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "problematic"""

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "p. 1029"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.122: Including the study by Rozzini et al. in our analyses would have overweighted the data of the Iowa cohort in the Established Populations for Epidemiologic Studies of the Elderly. 

Phrase: "Including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the study by Rozzini et al."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]

Phrase: "in our analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "would"

Phrase: "have"

Phrase: "overweighted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0497406:Overweight [Sign or Symptom]

Phrase: "the data of the Iowa cohort"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]

Phrase: "in the Established Populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "for Epidemiologic Studies"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0002783:Epidemiologic Studies [Research Activity]
   861   C0014507:Epidemiologic [Biomedical Occupation or Discipline]
   861   C0014508:epidemiologic [Functional Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
   789 E C0699910:epidemiology [Health Care Activity]

Phrase: "of the Elderly."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001792:Elderly [Population Group]
  1000   C1999167:elderly [Population Group]
Processing 00000000.tx.123: We could have chosen to include the study reported by Rozzini et al. in our analyses instead of the study by Saag et al. 

Phrase: "We"

Phrase: "could"

Phrase: "have"

Phrase: "chosen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Chosen [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "reported by Rozzini et al."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C1709908:Reported By [Group]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]

Phrase: "in our analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "instead of the study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "by Saag et al."
Processing 00000000.tx.124: This would have resulted in a lower pooled relative risk. 

Phrase: "This"

Phrase: "would"

Phrase: "have"

Phrase: "resulted in a lower pooled relative risk."
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   778   C0242492:Relative Risk [Quantitative Concept]
   748   C0035647:Risk [Qualitative Concept]
   748   C0080103:Relative [Family Group]
   748   C0205345:Relative [Qualitative Concept]
   748   C0441994:Lower [Spatial Concept]
   748   C1547039:*Relative [Quantitative Concept]
   748   C1548802:Lower [Body Location or Region]
   748   C1709595:Pooled [Conceptual Entity]
   748   C2003888:Lower [Activity]
   748   C2349200:Pooled [Functional Concept]
   714 E C0337051:Pool [Geographic Area]
   714   C1274040:Result [Functional Concept]
   714 E C1509144:pool [Clinical Attribute]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]
Processing 00000000.tx.125: However, including the study reported by Rozzini et al. instead of the study by Saag et al. does not affect our interpretation of the data. 

Phrase: "However,"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "reported by Rozzini et al."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C1709908:Reported By [Group]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]

Phrase: "instead of the study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "by Saag et al."

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "our interpretation of the data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0459471:Interpretation [Intellectual Product]
   760   C3173575:Interpretation [Clinical Attribute]
Processing 00000000.tx.126: The five studies that used cognitive decline as the endpoint all used different cognitive measures. 

Phrase: "The five"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205451:Five [Quantitative Concept]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "that used cognitive decline as the endpoint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   778   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]

Phrase: "all"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "different cognitive measures."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0079809:Measures [Quantitative Concept]
   827   C1879489:Measures [Functional Concept]
   793 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.127: Hence, we cannot exclude that NSAIDs might have a beneficial effect on a specific cognitive domain. 

Phrase: "Hence,"

Phrase: "we"

Phrase: "cannot"

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "that NSAIDs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0003211:Nonsteroidal Anti-inflammatory Drugs [Pharmacologic Substance]
   988 E C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   901   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   827   C0013227:Drugs [Pharmacologic Substance]
   827   C1515999:Anti-inflammatory [Qualitative Concept]
   793 E C1254351:Drug [Pharmacologic Substance]
   755 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   755 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   727 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "might"

Phrase: "have"

Phrase: "a beneficial effect on a specific cognitive domain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.128: However, on average, the effect of use of NSAIDs on cognitive decline is null, which is consistent with the finding that most randomized trials so far have shown: no beneficial effect on the course of dementia as measured with the cognitive subscale of the Alzheimers Disease Assessment Scale. 

Phrase: "However,"

Phrase: "on average,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510992:Average [Quantitative Concept]
  1000   C2825518:AVERAGE [Quantitative Concept]

Phrase: "the effect of use of NSAIDs"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   793   C0728866:effect of drugs [Functional Concept]
           Drug effect
   767   C1515999:Anti-inflammatory effect [Qualitative Concept]
   767   C1516019:Antiinflammatory Effect [Physiologic Function]
   750   C0728867:Drug effect [Pathologic Function]
   750   C1411996:drug effect [Biologic Function]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "on cognitive decline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]

Phrase: "is"

Phrase: "null,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456148:Null [Quantitative Concept]

Phrase: "which"

Phrase: "is"

Phrase: "consistent with the finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent
   783   C0332529:Consistency finding [Qualitative Concept]

Phrase: "that"

Phrase: "most randomized trials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008976:Trial [Research Activity]

Phrase: "so"

Phrase: "far"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205108:far [Spatial Concept]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ":"

Phrase: "no beneficial effect on the course of dementia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1301751:No effect [Qualitative Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "as"

Phrase: "measured with the cognitive subscale of the Alzheimers Disease Assessment Scale."
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   756   C0002395:Alzheimers disease [Disease or Syndrome]
   756   C0450973:assessment scale [Intellectual Product]
   754   C0009241:cognitive disease [Mental or Behavioral Dysfunction]
   754   C0870300:cognitive assessment [Diagnostic Procedure]
   738   C0012634:Disease [Disease or Syndrome]
   738   C0175659:Scale [Medical Device]
   738   C0349674:Scale [Intellectual Product]
   738   C0444706:Measured [Qualitative Concept]
   738   C1261322:Assessment [Health Care Activity]
   738   C1516048:Assessment [Activity]
   738   C1516691:Cognitive [Functional Concept]
   738   C1947916:Scale [Activity]
   738   C3536777:Scale [Manufactured Object]
   738   C3541902:MEASURED [Diagnostic Procedure]
   704 E C0079809:Measure [Quantitative Concept]
   704 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.129: Moreover, the two studies that were excluded from our meta-analysis (2, 3) because a relative risk could not be extracted both showed no association between use of NSAID and cognitive decline. 

Phrase: "Moreover,"

Phrase: "the two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "that"

Phrase: "were"

Phrase: "excluded from our meta-analysis"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0282458:Meta-Analysis [Intellectual Product]
   806   C0920317:Meta-Analysis [Research Activity]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1042496:Meta [Eukaryote]
   760   C1524024:analysis [Functional Concept]
   760   C1554077:Excluded [Idea or Concept]
   760   C2828389:Excluded [Activity]
   726 E C0332196:Exclude [Functional Concept]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "because"

Phrase: "a relative risk"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242492:Relative Risk [Quantitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "both"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no association between use of NSAID"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0004083:Association [Mental Process]
   739   C0439849:Association [Qualitative Concept]
   739   C0596306:Association [Phenomenon or Process]
   739   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "cognitive decline."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]
Processing 00000000.tx.130: A recent meta-analysis of NSAIDs and risk of dementia concluded, "NSAIDs offer some protection against the development of Alzheimers disease" (41, p. 128). 

Phrase: "A recent meta-analysis of NSAIDs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0282458:Meta-Analysis [Intellectual Product]
   770   C0920317:Meta-Analysis [Research Activity]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1042496:Meta [Eukaryote]
   744   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "risk of dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0035647:Risk [Qualitative Concept]

Phrase: "concluded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: ","

Phrase: """NSAIDs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0003211:Nonsteroidal Anti-inflammatory Drugs [Pharmacologic Substance]
   988 E C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   901   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   827   C0013227:Drugs [Pharmacologic Substance]
   827   C1515999:Anti-inflammatory [Qualitative Concept]
   793 E C1254351:Drug [Pharmacologic Substance]
   755 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   755 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   727 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "offer"

Phrase: "some protection against the development of Alzheimers disease"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1545588:Protection [Finding]

Phrase: "(41,"

Phrase: "p. 128"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.131: This conclusion was based mainly on the observation that short-term users (<1 month) had far less risk reduction than long-term users (>24 months) (relative risk = 0.95 vs. 0.27, respectively). 

Phrase: "This conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "was"

Phrase: "based"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1527178:Based [Functional Concept]
  1000   C1705938:Based [Idea or Concept]
   966 E C0002055:base [Inorganic Chemical]
   966 E C0178499:Base [Chemical Viewed Functionally]
   966 E C1880279:Base [Biomedical or Dental Material]

Phrase: "mainly on the observation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0302523:Observation [Research Activity]
   770   C0700325:observation [Health Care Activity]
   770   C1964257:Observation [Diagnostic Procedure]

Phrase: "that short-term users"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1706077:Users [Human]
   793 E C1548600:User [Idea or Concept]
   734   C0443303:Short-term [Temporal Concept]

Phrase: "("

Phrase: "<1 month"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442451:1 Month [Temporal Concept]
   861   C0439231:month [Temporal Concept]
   861   C0439507:/month [Temporal Concept]

Phrase: ")"

Phrase: "had"

Phrase: "far less"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205108:far [Spatial Concept]

Phrase: "risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "reduction than long-term users"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: ">24 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: ")"

Phrase: "(relative risk"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242492:Relative Risk [Quantitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: "= 0.95"

Phrase: "vs. 0.27,"

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.132: These authors did not address possible confounding factors (42), nor did they explain the discrepancy between the studies with prevalent cases and the studies with incident cases. 

Phrase: "These authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "possible confounding factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "(42"

Phrase: ")"

Phrase: ","

Phrase: "nor"

Phrase: "did"

Phrase: "they"

Phrase: "explain"

Phrase: "the discrepancy between the studies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1290905:Discrepancy [Finding]

Phrase: "with prevalent cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "the studies with incident cases."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   781   C0085973:Case Studies [Intellectual Product]
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]
Processing 00000000.tx.133: Again, the discrepancy in risk reduction between short-term and long-term users can well be explained by recall bias and prescription bias. 

Phrase: "Again,"

Phrase: "the discrepancy in risk reduction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1290905:Discrepancy [Finding]

Phrase: "between short-term"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0443303:Short-term [Temporal Concept]
   861   C1282927:short [Qualitative Concept]
   861   C1515273:Term [Temporal Concept]
   861   C1705313:Term [Idea or Concept]
   861   C1806781:Short [Quantitative Concept]
   861   C2350002:Short [Quantitative Concept]
   861   C2826302:TERM [Intellectual Product]

Phrase: "and"

Phrase: "long-term users"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1706077:Users [Human]
   793 E C1548600:User [Idea or Concept]
   734   C0443252:Long-term [Temporal Concept]

Phrase: "can"

Phrase: "well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "be"

Phrase: "explained by recall bias"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0034770:Recall [Mental Process]
   770   C0242568:Bias [Idea or Concept]
   770   C1504315:Bias [Bird]
   770   C1705180:Recall [Governmental or Regulatory Activity]
   770   C2361119:Recall [Clinical Attribute]
   737 E C1061346:Bia [Eukaryote]
   737 E C1704746:BIA [Diagnostic Procedure]

Phrase: "and"

Phrase: "prescription bias."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0242568:Bias [Idea or Concept]
   861   C1504315:Bias [Bird]
   827 E C1061346:Bia [Eukaryote]
   827 E C1704746:BIA [Diagnostic Procedure]
Processing 00000000.tx.134: By including studies with cognitive decline as the endpoint and thereby creating more distance between exposure and effect, we now demonstrate that bias and confounding are more likely explanations for the observed association. 

Phrase: "By"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "studies with cognitive decline"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "as the endpoint"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2349179:End Point [Qualitative Concept]
  1000   C2826544:ENDPOINT [Quantitative Concept]

Phrase: "and"

Phrase: "thereby"

Phrase: "creating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1706214:Create [Activity]
   966   C3244320:create [Functional Concept]

Phrase: "more distance between exposure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0012751:Distance [Quantitative Concept]

Phrase: "and"

Phrase: "effect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "we now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "demonstrate"

Phrase: "that bias"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0242568:Bias [Idea or Concept]
  1000   C1504315:Bias [Bird]
   966 E C1061346:Bia [Eukaryote]
   966 E C1704746:BIA [Diagnostic Procedure]

Phrase: "and"

Phrase: "confounding"

Phrase: "are"

Phrase: "more likely explanations for the observed association."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0681841:Explanations [Intellectual Product]
Processing 00000000.tx.135: Traditional teaching holds Alzheimers disease and vascular dementia as two separate clinical entities that can be differentiated by careful clinical and necropsy evaluation. 

Phrase: "Traditional teaching"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039401:Teaching [Educational Activity]
   861   C0220924:teaching [Educational Activity]
   861   C1548344:Teaching [Intellectual Product]

Phrase: "holds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1553387:Hold [Idea or Concept]
  1000   C1948035:Hold [Activity]

Phrase: "Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "vascular dementia as two separate clinical entities"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0011269:Dementia, Vascular [Disease or Syndrome]
   748   C0005847:vascular [Body Part, Organ, or Organ Component]
   748   C0011265:dementia [Mental or Behavioral Dysfunction]
   748   C0497327:Dementia [Mental or Behavioral Dysfunction]
   748   C1558950:VASCULAR [Finding]
   748   C1801960:Vascular [Qualitative Concept]

Phrase: "that"

Phrase: "can"

Phrase: "be"

Phrase: "differentiated by careful clinical"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007589:Differentiated [Cell Function]
   770   C0205210:Clinical [Qualitative Concept]
   770   C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "necropsy evaluation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220825:Evaluation [Functional Concept]
   861   C1261322:Evaluation [Health Care Activity]
Processing 00000000.tx.136: Several recent observations, however, suggest that the situation might be different. 

Phrase: "Several recent observations,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0302523:observations [Research Activity]
   827   C0700325:observations [Health Care Activity]
   827   C3244290:observations [Functional Concept]
   793 E C1964257:Observation [Diagnostic Procedure]
   743 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "however,"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the situation"

Phrase: "might"

Phrase: "be"

Phrase: "different."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1705242:Different [Qualitative Concept]
   928 E C1705241:*Difference [Quantitative Concept]
   900 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.137: Vascular risk factors also contribute to Alzheimers disease (43) and, conversely, -amyloid depositions are also frequently found in subjects with vascular dementia (44). 

Phrase: "Vascular risk factors also"
Meta Candidates (Total=15; Excluded=6; Pruned=0; Remaining=9)
   861   C0035648:risk factors [Quantitative Concept]
   861   C1553898:risk factors [Idea or Concept]
   858   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0035647:Risk [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "contribute to Alzheimers disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0002395:Alzheimers disease [Disease or Syndrome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1880177:Contribute [Activity]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "(43"

Phrase: ")"

Phrase: "and"

Phrase: ","

Phrase: "conversely, -"

Phrase: "amyloid depositions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011560:Amyloid Depositions [Pathologic Function]
   983 E C1705760:Amyloid Deposition [Finding]
   861   C0333562:DEPOSITIONS [Functional Concept]

Phrase: "are"

Phrase: "also frequently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332183:Frequently [Temporal Concept]

Phrase: "found in subjects"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with vascular dementia"
Meta Candidates (Total=14; Excluded=8; Pruned=0; Remaining=6)
  1000   C0011269:Dementia, Vascular [Disease or Syndrome]
   861   C0005847:vascular [Body Part, Organ, or Organ Component]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   861   C1558950:VASCULAR [Finding]
   861   C1801960:Vascular [Qualitative Concept]
   805 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   805 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C0005767:Blood [Tissue]
   761 E C0005768:blood [Body Substance]
   761 E C0229664:Blood [Body Substance]
   761 E C0392895:Bloods [Population Group]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]
   745 E C0333275:Bloody [Qualitative Concept]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.138: Hence, it is likely that Alzheimers disease and vascular dementia are two extreme expressions of one disease entity, dementia (45). 

Phrase: "Hence,"

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "vascular dementia"
Meta Candidates (Total=14; Excluded=8; Pruned=0; Remaining=6)
  1000   C0011269:Dementia, Vascular [Disease or Syndrome]
   861   C0005847:vascular [Body Part, Organ, or Organ Component]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   861   C1558950:VASCULAR [Finding]
   861   C1801960:Vascular [Qualitative Concept]
   805 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   805 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C0005767:Blood [Tissue]
   761 E C0005768:blood [Body Substance]
   761 E C0229664:Blood [Body Substance]
   761 E C0392895:Bloods [Population Group]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]
   745 E C0333275:Bloody [Qualitative Concept]

Phrase: "are"

Phrase: "two extreme expressions of one disease entity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:expressions [Therapeutic or Preventive Procedure]

Phrase: "dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.139: A prominent feature of both disease entities is progressive cognitive decline. 

Phrase: "A prominent feature of both disease entities"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C1531957:Feature of entity [Finding]
   748   C1521970:Feature [Qualitative Concept]
   748   C1706388:Feature [Conceptual Entity]
   748   C2346469:Feature [Qualitative Concept]
   748   C2348519:Feature [Qualitative Concept]

Phrase: "is"

Phrase: "progressive cognitive decline."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1863063:Cognitive decline, progressive [Finding]
   901   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]
Processing 00000000.tx.140: Hence, combining and comparing the various endpoints in one analysis gives a good indication for the possible benefits of NSAIDs in the various stages of the disease. 

Phrase: "Hence,"

Phrase: "combining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0336789:Combine [Manufactured Object]

Phrase: "and"

Phrase: "comparing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707455:Compare [Activity]

Phrase: "the various endpoints in one analysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C2349179:endpoints [Qualitative Concept]
   719 E C2826544:ENDPOINT [Quantitative Concept]

Phrase: "gives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "a good indication for the possible benefits of NSAIDs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0392360:indication [Idea or Concept]
   738   C3146298:Indication [Functional Concept]

Phrase: "in the various stages"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1306673:Stages [Qualitative Concept]
   827 E C0205390:Stage [Temporal Concept]
   827 E C1300072:Stage [Clinical Attribute]

Phrase: "of the disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.141: Until now, most randomized clinical trials have found no beneficial effect of NSAIDs in preventing cognitive decline (3133). 

Phrase: "Until"

Phrase: "now,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "most randomized clinical trials"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0206034:Clinical Trials, Randomized [Intellectual Product,Research Activity]
   901   C0008976:Clinical Trials [Research Activity]
           Trial
   901   C1096775:clinical trials [Intellectual Product]
   827   C0034656:randomized [Research Activity]
   827   C0205210:Clinical [Qualitative Concept]

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no beneficial effect of NSAIDs"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   804   C0728866:effect of drugs [Functional Concept]
           Drug effect
   789   C0542119:NO DRUG EFFECT [Finding]
   789   C0683156:beneficial drug effect [Biologic Function]
   774   C1301751:No effect [Qualitative Concept]
   774   C1515999:Anti-inflammatory effect [Qualitative Concept]
   774   C1516019:Antiinflammatory Effect [Physiologic Function]
   757   C0728867:Drug effect [Pathologic Function]
   757   C1411996:drug effect [Biologic Function]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "in preventing cognitive decline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]

Phrase: "(3133"

Phrase: ")."
Processing 00000000.tx.142: There might be three explanations for these negative studies. 

Phrase: "There"

Phrase: "might"

Phrase: "be"

Phrase: "three explanations for these negative studies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0681841:Explanations [Intellectual Product]
Processing 00000000.tx.143: First, there is no protective effect of NSAIDs. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "there"

Phrase: "is"

Phrase: "no protective effect of NSAIDs."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   804   C0728866:effect of drugs [Functional Concept]
           Drug effect
   789   C0542119:NO DRUG EFFECT [Finding]
   789   C0678771:protective drug effect [Biologic Function]
   774   C1301751:No effect [Qualitative Concept]
   774   C1515999:Anti-inflammatory effect [Qualitative Concept]
   774   C1516019:Antiinflammatory Effect [Physiologic Function]
   757   C0728867:Drug effect [Pathologic Function]
   757   C1411996:drug effect [Biologic Function]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.144: Second, most of these studies were carried out in subjects with early signs of cognitive impairment. 

Phrase: "Second, most of these studies"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0205436:Second [Quantitative Concept]
   760   C0457385:Second [Temporal Concept]
   760   C0565930:/second [Quantitative Concept]
   760   C0947630:studies [Laboratory Procedure]
   760   C1561503:second [Idea or Concept]
   760   C1705190:Second [Qualitative Concept]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in subjects"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0439787:Out [Spatial Concept]
   790   C0849355:Out [Qualitative Concept]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with early signs"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0220912:signs [Functional Concept]
   861   C0220913:signs [Manufactured Object]
   861   C0311392:SIGNS [Finding]
   827 E C1547188:Sign [Idea or Concept]

Phrase: "of cognitive impairment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0338656:Cognitive impairment [Mental or Behavioral Dysfunction]
   861   C0684336:Impairment [Pathologic Function]
Processing 00000000.tx.145: Administration of antiinflammatory drugs at that point in the disease process might simply be too late. 

Phrase: "Administration of antiinflammatory drugs"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   819   C3469597:administration drugs [Health Care Activity]
   802 E C0150270:Drug administration [Health Care Activity]
   770   C0001554:Administration [Occupational Activity]
   770   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "at that point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552961:Point [Quantitative Concept]
  1000   C2347617:point [Quantitative Concept]

Phrase: "in the disease process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "might"

Phrase: "simply"

Phrase: "be"

Phrase: "too late."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205087:Late [Temporal Concept]
Processing 00000000.tx.146: Third, it has recently been demonstrated that various NSAIDs have differential propensities on the inflammatory response and deposition of -amyloid (46). 

Phrase: "Third,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "it"

Phrase: "has"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "demonstrated"

Phrase: "that various NSAIDs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   923   C0003211:Nonsteroidal Anti-inflammatory Drugs [Pharmacologic Substance]
   912 E C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   861   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   812   C0013227:Drugs [Pharmacologic Substance]
   812   C1515999:Anti-inflammatory [Qualitative Concept]
   779 E C1254351:Drug [Pharmacologic Substance]
   741 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   741 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   712 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "have"

Phrase: "differential propensities on the inflammatory response"

Phrase: "and"

Phrase: "deposition of -amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.147: This finding calls for identification of the critical pathways in the inflammatory response and the corresponding drugs that are capable of interfering in that pathway. 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "calls for identification of the critical pathways"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0282655:Critical Pathways [Intellectual Product]
   748   C0020792:Identification [Mental Process]
   748   C0205396:Identification [Qualitative Concept]
   748   C0679006:Call [Mental Process]
   748   C1511545:Critical [Qualitative Concept]
   748   C1704259:Pathways [Molecular Function]
   748   C1705987:Pathways [Conceptual Entity]
   748   C1947967:Call [Functional Concept]

Phrase: "in the inflammatory response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1155266:Inflammatory Response [Pathologic Function]
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "the corresponding drugs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0013227:Drugs [Pharmacologic Substance]
   827 E C1254351:Drug [Pharmacologic Substance]
   789 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   789 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   761 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "that"

Phrase: "are"

Phrase: "capable of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   761   C2698977:Capability [Qualitative Concept]

Phrase: "interfering in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0521102:interfering [Qualitative Concept]

Phrase: "that pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathway [Molecular Function]
  1000   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.148: In conclusion, the benefit of NSAIDs in preventing dementia or cognitive impairment was 50 percent in studies with prevalent dementia cases, declined to 20 percent in studies with incident dementia cases, and was absent in studies where cognitive decline was used as the endpoint. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "the benefit of NSAIDs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0814225:Benefit [Quantitative Concept]

Phrase: "in preventing dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "or"

Phrase: "cognitive impairment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0338656:Cognitive impairment [Mental or Behavioral Dysfunction]
   861   C0684336:Impairment [Pathologic Function]

Phrase: "was"

Phrase: "50 percent in studies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439165:Percent [Quantitative Concept]

Phrase: "with prevalent dementia cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "declined to 20 percent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439165:Percent [Quantitative Concept]

Phrase: "in studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "with incident dementia cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "was"

Phrase: "absent in studies where cognitive decline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:Absent [Quantitative Concept]
   753   C2699517:ABSENT [Finding]

Phrase: "was"

Phrase: "used as the endpoint."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C1273517:used [Finding]
   770   C2349179:End Point [Qualitative Concept]
   770   C2826544:ENDPOINT [Quantitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.149: This indicates that most of the beneficial effects of NSAIDs from observational studies are likely to be the result of recall bias, prescription bias, and publication bias. 

Phrase: "This"

Phrase: "indicates"

Phrase: "that most of the beneficial effects of NSAIDs"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   782   C0003211:Nonsteroidal Anti-inflammatory Drugs [Pharmacologic Substance]
   771 E C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   764   C0728866:effect of drugs [Functional Concept]
           drug effects
   760   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   753   C0683156:beneficial drug effect [Biologic Function]
   741   C1515999:Anti-inflammatory effect [Qualitative Concept]
           Anti-inflammatory
   741   C1516019:Antiinflammatory Effect [Physiologic Function]
   739   C0013227:Drugs [Pharmacologic Substance]
   739   C1280500:effects [Qualitative Concept]
   724 E C0728867:Drug effect [Pathologic Function]
   724 E C1411996:drug effect [Biologic Function]
   706 E C1254351:Drug [Pharmacologic Substance]
   706 E C2348382:Effect [Qualitative Concept]

Phrase: "from observational studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C1518527:Observational Study [Research Activity]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "the result of recall bias,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "prescription bias,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0242568:Bias [Idea or Concept]
   861   C1504315:Bias [Bird]
   827 E C1061346:Bia [Eukaryote]
   827 E C1704746:BIA [Diagnostic Procedure]

Phrase: "and"

Phrase: "publication bias."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0206086:Publication Bias [Qualitative Concept]
   861   C0242568:Bias [Idea or Concept]
   861   C1504315:Bias [Bird]
   827 E C1061346:Bia [Eukaryote]
   827 E C1704746:BIA [Diagnostic Procedure]
Processing 00000000.tx.150: Before further large and costly trials are designed to assess the potential protective effects of NSAIDS, the specific critical pathways in the inflammatory process in dementia amendable to drug intervention should be identified.  

Phrase: "Before further large"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0549177:Large [Quantitative Concept]

Phrase: "and"

Phrase: "costly trials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008976:Trial [Research Activity]

Phrase: "are"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the potential protective effects of NSAIDS,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "the specific critical pathways in the inflammatory process"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0282655:Critical Pathways [Intellectual Product]
   744   C1704259:Pathways [Molecular Function]
   744   C1705987:Pathways [Conceptual Entity]

Phrase: "in dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "amendable to drug intervention"

Phrase: "should"

Phrase: "be"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.151: NOTES  Correspondence to Dr. 

Phrase: "NOTES"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "Correspondence to Dr."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0282413:Correspondence [Intellectual Product]
Processing 00000000.tx.152: A. 

Phrase: "A."
Processing 00000000.tx.153: J. 

Phrase: "J."
Processing 00000000.tx.154: M. de Craen, Section of Gerontology and Geriatrics, C2-R, Leiden University Medical Center, P.O. 

Phrase: "M. de Craen,"

Phrase: "Section of Gerontology"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0205155:Section [Spatial Concept]
   790   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   790   C1522472:Section [Substance]
   790   C1552923:Section [Quantitative Concept]
   790   C1705191:Section [Physical Object]

Phrase: "and"

Phrase: "Geriatrics,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017469:Geriatrics [Biomedical Occupation or Discipline]
  1000   C1552300:Geriatrics [Professional or Occupational Group]
   966 E C1704440:Geriatric [Qualitative Concept]
   966 E C1999167:geriatric [Population Group]

Phrase: "C2-R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Leiden University Medical Center,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   861   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   861   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   812   C0041740:University [Manufactured Object,Organization]
   812   C0205099:Center [Spatial Concept]
   812   C0205476:Medical [Functional Concept]

Phrase: "P.O."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.155: Box 9600, Leiden 2300 RC, the Netherlands (e-mail: craen{at}lumc.nl ).  

Phrase: "Box 9600,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179400:Box [Manufactured Object]
   861   C1533124:Box [Medical Device]

Phrase: "Leiden 2300 RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1419366:RC [Gene or Genome]

Phrase: "the Netherlands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027778:The Netherlands [Geographic Area]
           Netherlands

Phrase: "(e-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "craen{at}lumc.nl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0027778:NL [Geographic Area]
   812   C0560008:nL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.156: REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Mackenzie IRA, Munoz DG. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Mackenzie IRA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1512960:IRA [Governmental or Regulatory Activity]
   861   C2817684:Ira [Eukaryote]

Phrase: "Munoz DG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1275573:dg [Quantitative Concept]
Processing 00000000.tx.157: Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging. 

Phrase: "Nonsteroidal anti-inflammatory drug use"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0242510:drug use [Mental or Behavioral Dysfunction]
   804   C0042153:use [Functional Concept]
   804   C0457083:Use [Functional Concept]
   804   C1947944:Use [Intellectual Product]
   771   C0003211:Non-steroidal anti-inflammatory drug [Pharmacologic Substance]
   771   C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   717   C0003209:anti inflammatory drug [Pharmacologic Substance]

Phrase: "and"

Phrase: "Alzheimer-type pathology in aging."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030664:Pathology [Biomedical Occupation or Discipline]
   760   C0205469:pathology [Functional Concept]
   760   C0677042:pathology [Pathologic Function]
Processing 00000000.tx.158: Neurology 1998;50:98690.[Abstract] May FE, Moore MT, Stewart RB, et al. 

Phrase: "Neurology 1998"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";50"

Phrase: ":"

Phrase: "98690."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] May FE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346593:Fe+++ [Element, Ion, or Isotope]

Phrase: "Moore MT,"

Phrase: "Stewart RB,"

Phrase: "et al."
Processing 00000000.tx.159: Lack of association of nonsteroidal anti-inflammatory drug use and cognitive decline in the elderly. 

Phrase: "Lack of association of nonsteroidal anti-inflammatory drug use"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0332268:lack [Qualitative Concept]

Phrase: "and"

Phrase: "cognitive decline in the elderly."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]
Processing 00000000.tx.160: Gerontology 1992;38:2759.[ISI][Medline] Prince M, Rabe-Hesketh S, Brennan P. 

Phrase: "Gerontology 1992"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017469:Gerontology [Biomedical Occupation or Discipline]
   861   C0205767:Gerontology [Occupation or Discipline]

Phrase: ";38"

Phrase: ":"

Phrase: "2759."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Prince M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Rabe-Hesketh S,"

Phrase: "Brennan P."
Processing 00000000.tx.161: Do antiarthritic drugs decrease the risk for cognitive decline? 

Phrase: "Do"

Phrase: "antiarthritic drugs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0013227:Drugs [Pharmacologic Substance]
   827 E C1254351:Drug [Pharmacologic Substance]
   789 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   789 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   761 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the risk for cognitive decline?"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.162: Neurology 1998;50:3749.[Abstract] Rich JB, Rasmusson DX, Folstein MF, et al. 

Phrase: "Neurology 1998"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";50"

Phrase: ":"

Phrase: "3749."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Rich JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: "Rasmusson DX,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538936:DX [Idea or Concept]

Phrase: "Folstein MF,"

Phrase: "et al."
Processing 00000000.tx.163: Nonsteroidal anti-inflammatory drugs in Alzheimers disease. 

Phrase: "Nonsteroidal anti-inflammatory drugs in Alzheimers disease."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   853   C0003211:Nonsteroidal Anti-inflammatory Drugs [Pharmacologic Substance]
   842 E C3536840:Non-steroidal Antiinflammatory Drug [Pharmacologic Substance]
   814   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   778   C1515999:Anti-inflammatory [Qualitative Concept]
   774   C1290884:Inflammatory disease [Disease or Syndrome]
   748   C0013227:Drugs [Pharmacologic Substance]
   748   C0333348:Inflammatory [Functional Concept]
   714 E C1254351:Drug [Pharmacologic Substance]
Processing 00000000.tx.164: Neurology 1995;45:515.[Abstract] Rozzini R, Ferrucci L, Losonczy K, et al. 

Phrase: "Neurology 1995"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";45"

Phrase: ":"

Phrase: "515."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Rozzini R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Ferrucci L,"

Phrase: "Losonczy K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.165: Protective effect of chronic NSAID use on cognitive decline in older persons. 

Phrase: "Protective effect of chronic NSAID use"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   777   C1515999:Anti-inflammatory effect [Qualitative Concept]
   777   C1516019:Antiinflammatory Effect [Physiologic Function]
   775   C0678771:protective drug effect [Biologic Function]
   775   C0678783:chronic drug effect [Biologic Function]
   757   C0728866:Drug effect [Functional Concept]
           effect of drugs
   757   C0728867:Drug effect [Pathologic Function]
   757   C1411996:drug effect [Biologic Function]
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "on cognitive decline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]

Phrase: "in older persons."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027361:Persons [Population Group]
   827 E C2347489:Person [Group]
   777 E C1519021:Personal [Organism Attribute]
Processing 00000000.tx.166: J Am Geriatr Soc 1996;44:10259.[ISI][Medline] McGeer PL, Harada N, Kimura H, et al. 

Phrase: "J"

Phrase: "Am"

Phrase: "Geriatr Soc 1996"

Phrase: ";44"

Phrase: ":"

Phrase: "10259."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] McGeer PL,"

Phrase: "Harada N,"

Phrase: "Kimura H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.167: Prevalence of dementia amongst elderly Japanese with leprosy: apparent effect of chronic drug therapy. 

Phrase: "Prevalence of dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0033105:Prevalence [Quantitative Concept]
   790   C0220900:prevalence [Quantitative Concept]

Phrase: "amongst elderly Japanese"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1556094:Japanese [Population Group]

Phrase: "with leprosy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023343:Leprosy [Disease or Syndrome]
  1000   C0051981:leprosy [Immunologic Factor,Pharmacologic Substance]

Phrase: ":"

Phrase: "apparent effect of chronic drug therapy."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   820   C0678783:chronic drug effect [Biologic Function]
   793   C0728866:effect of drugs [Functional Concept]
           Drug effect
   783   C0728867:Drug effect [Pathologic Function]
   783   C1411996:drug effect [Biologic Function]
   783   C1518681:Therapy Effect [Finding]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.168: Dementia 1992;3:1469.[ISI] Breitner JCS, Gau BA, Welsh KA, et al. 

Phrase: "Dementia 1992"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: ";3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ":"

Phrase: "1469."

Phrase: "[ISI] Breitner JCS,"

Phrase: "Gau BA,"

Phrase: "Welsh KA,"

Phrase: "et al."
Processing 00000000.tx.169: Inverse association of anti-inflammatory treatments and Alzheimers disease: initial results of a co-twin control study. 

Phrase: "Inverse association of anti-inflammatory treatments"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1708567:Inverse Association [Conceptual Entity]
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "initial results of a co-twin control study."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0683954:results study [Finding]
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]
Processing 00000000.tx.170: Neurology 1994;44:22732.[Abstract] The Canadian Study of Health and Aging: risk factors for Alzheimers disease in Canada. 

Phrase: "Neurology 1994"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";44"

Phrase: ":"

Phrase: "22732."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"

Phrase: "The Canadian"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238884:CANADIAN [Finding]

Phrase: "Study of Health"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0018684:Health [Idea or Concept]
   790   C0557651:Study [Manufactured Object]
   790   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "Aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: ":"

Phrase: "risk factors for Alzheimers disease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   835   C0850664:disease factors risk [Finding]
   806   C0035648:risk factors [Quantitative Concept]
   806   C1553898:risk factors [Idea or Concept]
   797   C0679238:disease factors [Functional Concept]
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]

Phrase: "in Canada."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]
Processing 00000000.tx.171: Neurology 1994;44:207380.[Abstract] Lucca U, Tettamanti M, Forloni G, et al. 

Phrase: "Neurology 1994"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";44"

Phrase: ":"

Phrase: "207380."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lucca U,"

Phrase: "Tettamanti M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Forloni G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.172: Nonsteroidal antiinflammatory drug use in Alzheimers disease. 

Phrase: "Nonsteroidal antiinflammatory drug use in Alzheimers disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0242510:drug use [Mental or Behavioral Dysfunction]
   748   C0042153:use [Functional Concept]
   748   C0457083:Use [Functional Concept]
   748   C1947944:Use [Intellectual Product]
Processing 00000000.tx.173: Biol Psychiatry 1994;36:8546.[CrossRef][ISI][Medline] Andersen K, Launer LJ, Ott A, et al. 

Phrase: "Biol Psychiatry 1994"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0033872:Psychiatry [Professional or Occupational Group]
   827   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   755 E C0205487:Psychiatric [Functional Concept]

Phrase: ";36"

Phrase: ":"

Phrase: "8546."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Andersen K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Launer LJ,"

Phrase: "Ott A,"

Phrase: "et al."
Processing 00000000.tx.174: Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimers disease? 

Phrase: "Do"

Phrase: "nonsteroidal anti-inflammatory drugs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0003211:Nonsteroidal Anti-inflammatory Drugs [Pharmacologic Substance]
   988 E C3536840:Non-steroidal Antiinflammatory Drug [Pharmacologic Substance]
   923   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   861   C1515999:Anti-inflammatory [Qualitative Concept]
   812   C0013227:Drugs [Pharmacologic Substance]
   812   C0333348:Inflammatory [Functional Concept]
   779 E C1254351:Drug [Pharmacologic Substance]
   741 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   741 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   712 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the risk for Alzheimers disease?"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.175: The Rotterdam Study. 

Phrase: "The Rotterdam Study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.176: Neurology 1995;45:14415.[Abstract] Breitner JCS, Welsh KA, Helms MJ, et al. 

Phrase: "Neurology 1995"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";45"

Phrase: ":"

Phrase: "14415."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Breitner JCS,"

Phrase: "Welsh KA,"

Phrase: "Helms MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "et al."
Processing 00000000.tx.177: Delayed onset of Alzheimers disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. 

Phrase: "Delayed onset of Alzheimers disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0277793:disease onset [Temporal Concept]
   760   C0332162:Onset [Qualitative Concept]

Phrase: "with nonsteroidal anti-inflammatory"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0003209:Anti-inflammatory [Pharmacologic Substance]
   901   C1515999:Anti-inflammatory [Qualitative Concept]
   827   C0333348:Inflammatory [Functional Concept]

Phrase: "and"

Phrase: "histamine H2 blocking drugs."
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   902   C0242704:Histamine Drugs [Pharmacologic Substance]
   861   C2955666:blocking drugs [Functional Concept]
   827 E C0331791:Block Drug [Health Care Related Organization]
   812   C0013227:Drugs [Pharmacologic Substance]
   779 E C1254351:Drug [Pharmacologic Substance]
   741 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   741 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   712 E C0456386:Medicament [Pharmacologic Substance]
Processing 00000000.tx.178: Neurobiol Aging 1995;16:52330.[CrossRef][ISI][Medline] Endoh M, Kunishita T, Tabira T. 

Phrase: "Neurobiol"

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "1995"

Phrase: ";16"

Phrase: ":"

Phrase: "52330."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Endoh M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kunishita T,"

Phrase: "Tabira T."
Processing 00000000.tx.179: No effect of anti-leprosy drugs in the prevention of Alzheimers disease and -amyloid neurotoxicity. 

Phrase: "No effect of anti-leprosy drugs"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   820   C0728866:effect of drugs [Functional Concept]
           Drug effect
   803   C0542119:NO DRUG EFFECT [Finding]
   790   C1301751:No effect [Qualitative Concept]
   767   C0728867:Drug effect [Pathologic Function]
   767   C1411996:drug effect [Biologic Function]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "in the prevention"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0199176:Prevention [Therapeutic or Preventive Procedure]
  1000   C1706420:PREVENTION [Research Activity]
  1000   C2700409:prevention [Qualitative Concept]

Phrase: "of Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and -"

Phrase: "amyloid neurotoxicity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0235032:Neurotoxicity [Injury or Poisoning]
Processing 00000000.tx.180: J Neurol Sci 1999;165:2830.[CrossRef][ISI][Medline] Anthony JC, Breitner JCS, Zandi PP, et al. 

Phrase: "J Neurol Sci 1999"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3642273:SCI [Professional or Occupational Group]

Phrase: ";165"

Phrase: ":"

Phrase: "2830."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Anthony JC,"

Phrase: "Breitner JCS,"

Phrase: "Zandi PP,"

Phrase: "et al."
Processing 00000000.tx.181: Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists. 

Phrase: "Reduced prevalence of AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033105:Prevalence [Quantitative Concept]
   770   C0220900:prevalence [Quantitative Concept]

Phrase: "in users"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706077:Users [Human]
   966 E C1548600:User [Idea or Concept]

Phrase: "of NSAIDs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0003211:Nonsteroidal Anti-inflammatory Drugs [Pharmacologic Substance]
   988 E C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   901   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   827   C0013227:Drugs [Pharmacologic Substance]
   827   C1515999:Anti-inflammatory [Qualitative Concept]
   793 E C1254351:Drug [Pharmacologic Substance]
   755 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   755 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   727 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "and"

Phrase: "H2 receptor antagonists."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C2757005:H2 Receptor Antagonists [Molecular Function]
   988 E C0019593:H2 Receptor Antagonist [Pharmacologic Substance]
           H2 Antagonist
   988 E C3536872:H2 Receptor Antagonist [Pharmacologic Substance]
   827   C0243076:antagonists [Chemical Viewed Functionally]
   793 E C0231491:Antagonist [Organ or Tissue Function]
   734   C0034815:H2 receptor [Amino Acid, Peptide, or Protein,Receptor]
   721 E C0680242:antagonism [Social Behavior]
Processing 00000000.tx.182: Neurology 2000;54:206671.[Abstract/Free FullText] Broe GA, Grayson DA, Creasey HM, et al. 

Phrase: "Neurology 2000"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";54"

Phrase: ":"

Phrase: "206671."

Phrase: "[Abstract/Free FullText"

Phrase: "] Broe GA,"

Phrase: "Grayson DA,"

Phrase: "Creasey HM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0262500:hm [Health Care Activity]
   861   C1512358:HM [Geographic Area]
   861   C3538713:HM [Idea or Concept]

Phrase: "et al."
Processing 00000000.tx.183: Anti-inflammatory drugs protect against Alzheimer disease at low doses. 

Phrase: "Anti-inflammatory drugs"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   901   C1515999:Anti-inflammatory [Qualitative Concept]
   827   C0013227:Drugs [Pharmacologic Substance]
   827   C0333348:Inflammatory [Functional Concept]
   793 E C1254351:Drug [Pharmacologic Substance]
   755 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   755 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   727 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "protect against Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "at low doses."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0445550:Low dose [Quantitative Concept]
   983   C1708745:Low-Dose [Research Activity]
   861   C0178602:Doses [Quantitative Concept]
   827 E C0869039:Dose [Quantitative Concept]
   827 E C1114758:Dose # [Clinical Attribute]
   827 E C1428722:DOS [Gene or Genome]
Processing 00000000.tx.184: Arch Neurol 2000;57:158691.[Abstract/Free FullText] Landi F, Cesari M, Onder G, et al. 

Phrase: "Arch Neurol 2000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0230467:arch [Body Location or Region]
   827   C0741204:ARCH [Body Space or Junction]

Phrase: ";57"

Phrase: ":"

Phrase: "158691."

Phrase: "[Abstract/Free FullText"

Phrase: "] Landi F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Cesari M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Onder G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.185: Non-steroidal anti-inflammatory drug (NSAID) use and Alzheimer disease in community-dwelling elderly patients. 

Phrase: "Non-steroidal anti-inflammatory drug (NSAID) use"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   840   C0281991:Steroid Use [Individual Behavior]
   827   C0242510:drug use [Mental or Behavioral Dysfunction]
   799   C0042153:use [Functional Concept]
   799   C0457083:Use [Functional Concept]
   799   C1947944:Use [Intellectual Product]
   780   C0003211:Non-steroidal anti-inflammatory drug [Pharmacologic Substance]
   780   C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   706   C0003212:steroidal anti-inflammatory drugs [Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "Alzheimer disease in community-dwelling elderly patients."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   748   C0012634:Disease [Disease or Syndrome]
Processing 00000000.tx.186: Am J Geriatr Psychiatry 2003;11:17985.[Abstract/Free FullText] Nilsson SE, Johansson B, Takkinen S, et al. 

Phrase: "Am"

Phrase: "J Geriatr Psychiatry 2003"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0033872:Psychiatry [Professional or Occupational Group]
   812   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   741 E C0205487:Psychiatric [Functional Concept]

Phrase: ";11"

Phrase: ":"

Phrase: "17985."

Phrase: "[Abstract/Free FullText"

Phrase: "] Nilsson SE,"

Phrase: "Johansson B,"

Phrase: "Takkinen S,"

Phrase: "et al."
Processing 00000000.tx.187: Does aspirin protect Alzheimers dementia? 

Phrase: "Does"

Phrase: "aspirin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004057:Aspirin [Organic Chemical,Pharmacologic Substance]
   944 E C0699274:Ecotrin [Organic Chemical,Pharmacologic Substance]

Phrase: "protect"

Phrase: "Alzheimers dementia?"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0002395:alzheimers dementia [Disease or Syndrome]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.188: A study in a Swedish population based sample aged 80 years. 

Phrase: "A study in a Swedish population based sample"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   793   C1709599:Population Based Study [Research Activity]
   789   C2348150:Sample Study Population [Population Group]
   767   C0681876:Population Study [Research Activity]
   767   C2348561:Study Population [Population Group]
   744   C0557651:Study [Manufactured Object]
   744   C2603343:Study [Research Activity]

Phrase: "aged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001779:Aged [Organism Attribute]
  1000   C0001792:Aged [Population Group]
  1000   C1999167:aged [Population Group]

Phrase: "80 years."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.189: Eur J Clin Pharmacol 2003;59:31319.[CrossRef] Kukull WA, Larson EB, Stergachis A, et al. 

Phrase: "Eur J Clin Pharmacol 2003"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1315013:CLIN [Intellectual Product]

Phrase: ";59"

Phrase: ":"

Phrase: "31319."

Phrase: "[CrossRef"

Phrase: "] Kukull WA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043038:WA [Geographic Area]

Phrase: "Larson EB,"

Phrase: "Stergachis A,"

Phrase: "et al."
Processing 00000000.tx.190: Non-steroidal anti-inflammatory drug use and risk of Alzheimers disease. 

Phrase: "Non-steroidal anti-inflammatory drug use"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   840   C0281991:Steroid Use [Individual Behavior]
   827   C0242510:drug use [Mental or Behavioral Dysfunction]
   799   C0042153:use [Functional Concept]
   799   C0457083:Use [Functional Concept]
   799   C1947944:Use [Intellectual Product]
   780   C0003211:Non-steroidal anti-inflammatory drug [Pharmacologic Substance]
   780   C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   706   C0003212:steroidal anti-inflammatory drugs [Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "risk of Alzheimers disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1281905:disease risk [Finding]
   770   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.191: (Abstract). 

Phrase: "(Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.192: Neurology 1994;44(suppl 2):A237. 

Phrase: "Neurology 1994"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";44"

Phrase: "(suppl 2"

Phrase: ")"

Phrase: ":"

Phrase: "A237."
Processing 00000000.tx.193: Fourrier A, Letenneur L, Bgaud B, et al. 

Phrase: "Fourrier"

Phrase: "A,"

Phrase: "Letenneur L,"

Phrase: "Bgaud B,"

Phrase: "et al."
Processing 00000000.tx.194: Nonsteroidal antiinflammatory drug use and cognitive function in the elderly: inconclusive results from a population-based cohort study. 

Phrase: "Nonsteroidal antiinflammatory drug use"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0242510:drug use [Mental or Behavioral Dysfunction]
   812   C0042153:use [Functional Concept]
   812   C0457083:Use [Functional Concept]
   812   C1947944:Use [Intellectual Product]
   756   C0003211:Non-steroidal anti-inflammatory drug [Pharmacologic Substance]
   756   C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]

Phrase: "and"

Phrase: "cognitive function in the elderly"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0392335:cognitive function [Mental Process]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1516691:Cognitive [Functional Concept]
   760   C1705273:Function [Intellectual Product]

Phrase: ":"

Phrase: "inconclusive results from a population-based cohort study."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0683954:results study [Finding]
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]
Processing 00000000.tx.195: J Clin Epidemiol 1996;49:1201.[CrossRef][ISI][Medline] Henderson AS, Jorm AF, Christensen H, et al. 

Phrase: "J Clin Epidemiol 1996"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1315013:CLIN [Intellectual Product]

Phrase: ";49"

Phrase: ":"

Phrase: "1201."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Henderson AS,"

Phrase: "Jorm AF,"

Phrase: "Christensen H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.196: Aspirin, anti-inflammatory drugs and risk of dementia. 

Phrase: "Aspirin,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004057:Aspirin [Organic Chemical,Pharmacologic Substance]
   944 E C0699274:Ecotrin [Organic Chemical,Pharmacologic Substance]

Phrase: "anti-inflammatory drugs"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   901   C1515999:Anti-inflammatory [Qualitative Concept]
   827   C0013227:Drugs [Pharmacologic Substance]
   827   C0333348:Inflammatory [Functional Concept]
   793 E C1254351:Drug [Pharmacologic Substance]
   755 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   755 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   727 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "and"

Phrase: "risk of dementia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.197: Int J Geriat Psychiatry 1997;12:92630.[CrossRef][ISI][Medline] Stewart WF, Kawas C, Corrada M, et al. 

Phrase: "Int J Geriat Psychiatry 1997"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C0033872:Psychiatry [Professional or Occupational Group]
   804   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   804   C0063789:INT [Organic Chemical]
   804   C3272375:INT [Intellectual Product]
   733 E C0205487:Psychiatric [Functional Concept]

Phrase: ";12"

Phrase: ":"

Phrase: "92630."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Stewart WF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043021:WF [Geographic Area]

Phrase: "Kawas C,"

Phrase: "Corrada M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.198: Risk of Alzheimers disease and duration of NSAID use. 

Phrase: "Risk of Alzheimers disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1281905:disease risk [Finding]
   770   C0035647:Risk [Qualitative Concept]

Phrase: "and"

Phrase: "duration of NSAID use."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   793   C1881378:DURATION OF USE [Functional Concept]
   793   C2826775:Duration of Use [Temporal Concept]
   744   C0449238:Duration [Temporal Concept]
   744   C2926735:Duration [Pharmacologic Substance]
   703   C0003211:Non-steroidal anti-inflammatory drug [Pharmacologic Substance]
   703   C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
Processing 00000000.tx.199: Neurology 1997;48:62632.[Abstract] Beard CM, Waring SC, OBrien PC, et al. 

Phrase: "Neurology 1997"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";48"

Phrase: ":"

Phrase: "62632."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Beard CM,"

Phrase: "Waring"

Phrase: "SC,"

Phrase: "OBrien PC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: "et al."
Processing 00000000.tx.200: Nonsteroidal anti-inflammatory drug use and Alzheimers disease. 

Phrase: "Nonsteroidal anti-inflammatory drug use"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0242510:drug use [Mental or Behavioral Dysfunction]
   804   C0042153:use [Functional Concept]
   804   C0457083:Use [Functional Concept]
   804   C1947944:Use [Intellectual Product]
   771   C0003211:Non-steroidal anti-inflammatory drug [Pharmacologic Substance]
   771   C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   717   C0003209:anti inflammatory drug [Pharmacologic Substance]

Phrase: "and"

Phrase: "Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.201: A case-control study in Rochester, Minnesota, 1980 through 1984. 

Phrase: "A case-control study in Rochester,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0007328:Case-Control Study [Research Activity]
   790   C0872128:case control [Health Care Activity]
   783   C0085973:Case Study [Intellectual Product]
   753   C0243148:control [Qualitative Concept]
   753   C0557651:Study [Manufactured Object]
   753   C0868928:Case [Functional Concept]
   753   C1550141:Control [Substance]
   753   C1706255:CASE [Medical Device]
   753   C1706256:Case [Conceptual Entity]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C2603343:Study [Research Activity]
   753   C3274648:Control [Qualitative Concept]

Phrase: "Minnesota,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026183:Minnesota [Geographic Area]

Phrase: "1980 through 1984."
Processing 00000000.tx.202: Mayo Clin Proc 1998;73:9515.[ISI][Medline] Cornelius C, Fratiglioni L, Fastbom J, et al. 

Phrase: "Mayo Clin Proc 1998"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0454788:Mayo [Geographic Area]
   812   C1077578:mayo [Plant]
   812   C1315013:CLIN [Intellectual Product]
   812   C1418943:PROC [Gene or Genome]

Phrase: ";73"

Phrase: ":"

Phrase: "9515."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cornelius C,"

Phrase: "Fratiglioni L,"

Phrase: "Fastbom J,"

Phrase: "et al."
Processing 00000000.tx.203: No support for a protective effect of NSAIDs against Alzheimers disease from a follow-up population based study. 

Phrase: "No support for a protective effect of NSAIDs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0183683:Support [Medical Device]
   739   C1521721:Support [Conceptual Entity]

Phrase: "against Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "from a follow-up population based study."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   911   C0016441:Follow-up Study [Research Activity]
   884   C1709599:Population Based Study [Research Activity]
   853   C0681876:Population Study [Research Activity]
   804   C0557651:Study [Manufactured Object]
   804   C2603343:Study [Research Activity]
Processing 00000000.tx.204: (Abstract). 

Phrase: "(Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.205: Neurobiol Aging 1998;19(suppl 4):S28. 

Phrase: "Neurobiol"

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "1998"

Phrase: ";19"

Phrase: "(suppl 4"

Phrase: ")"

Phrase: ":"

Phrase: "S28."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419731:S28 [Gene or Genome]
Processing 00000000.tx.206: in t Veld BA, Ruitenberg A, Hofman A, et al. 

Phrase: "in t Veld BA,"

Phrase: "Ruitenberg A,"

Phrase: "Hofman A,"

Phrase: "et al."
Processing 00000000.tx.207: Nonsteroidal antiinflammatory drugs and the risk of Alzheimers disease. 

Phrase: "Nonsteroidal antiinflammatory drugs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0003211:Nonsteroidal Anti-inflammatory Drugs [Pharmacologic Substance]
   988 E C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   901   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   827   C0013227:Drugs [Pharmacologic Substance]
   827   C1515999:Anti-inflammatory [Qualitative Concept]
   793 E C1254351:Drug [Pharmacologic Substance]
   755 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   755 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   727 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "and"

Phrase: "the risk of Alzheimers disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.208: N Engl J Med 2001;345:151521.[Abstract/Free FullText] Wolfson C, Perrault A, Moride A, et al. 

Phrase: "N Engl J Med 2001"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441922:N+ [Intellectual Product]
   804   C1414400:ENGL [Gene or Genome]
   804   C1553036:[n] [Quantitative Concept]

Phrase: ";345"

Phrase: ":"

Phrase: "151521."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wolfson C,"

Phrase: "Perrault A,"

Phrase: "Moride A,"

Phrase: "et al."
Processing 00000000.tx.209: A case-control analysis of nonsteroidal anti-inflammatory drugs and Alzheimers disease: are they protective? 

Phrase: "A case-control analysis of nonsteroidal anti-inflammatory drugs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "are"

Phrase: "they protective?"
Processing 00000000.tx.210: Neuroepidemiology 2002;21:816.[CrossRef][ISI][Medline] Lindsay J, Laurin D, Verreault R, et al. 

Phrase: "Neuroepidemiology 2002"

Phrase: ";21"

Phrase: ":"

Phrase: "816."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lindsay J,"

Phrase: "Laurin D,"

Phrase: "Verreault R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "et al."
Processing 00000000.tx.211: Risk factors for Alzheimers disease: a prospective analysis from the Canadian Study of Health and Aging. 

Phrase: "Risk factors for Alzheimers disease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   835   C0850664:disease factors risk [Finding]
   806   C0035648:risk factors [Quantitative Concept]
   806   C1553898:risk factors [Idea or Concept]
   797   C0679238:disease factors [Functional Concept]
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]

Phrase: ":"

Phrase: "a prospective analysis from the Canadian"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "Study of Health"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0018684:Health [Idea or Concept]
   790   C0557651:Study [Manufactured Object]
   790   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "Aging."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]
Processing 00000000.tx.212: Am J Epidemiol 2002;156:44553.[Abstract/Free FullText] Zandi PP, Anthony JC, Hayden KM, et al. 

Phrase: "Am"

Phrase: "J Epidemiol 2002"

Phrase: ";156"

Phrase: ":"

Phrase: "44553."

Phrase: "[Abstract/Free FullText"

Phrase: "] Zandi PP,"

Phrase: "Anthony JC,"

Phrase: "Hayden KM,"

Phrase: "et al."
Processing 00000000.tx.213: Reduced incidence of AD with NSAID but not H2 receptor antgonists. 

Phrase: "Reduced incidence of AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021149:Incidence [Quantitative Concept]
   770   C0220856:incidence [Functional Concept]

Phrase: "with NSAID"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
  1000   C0003211:Non-steroidal anti-inflammatory drug [Pharmacologic Substance]
  1000   C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   910   C0003212:steroidal anti-inflammatory drugs [Pharmacologic Substance,Steroid]
   884   C0003209:anti inflammatory drug [Pharmacologic Substance]
           Anti-inflammatory
   840   C1515999:Anti-inflammatory [Qualitative Concept]
   839   C0260264:steroid drug [Steroid]
   804   C0013227:Drug [Pharmacologic Substance]
   804   C0333348:Inflammatory [Functional Concept]
   804   C1254351:Drug [Pharmacologic Substance]
   804   C1518422:Non [Functional Concept]
   748 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   748 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   733   C0038317:Steroid [Steroid]
   711 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "but"

Phrase: "not H2 receptor antgonists."
Processing 00000000.tx.214: The Cache County Study. 

Phrase: "The Cache County Study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]
Processing 00000000.tx.215: Neurology 2002;59:8806.[Abstract/Free FullText] Saag KG, Rubenstein LM, Chrischilles EA, et al. 

Phrase: "Neurology 2002"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";59"

Phrase: ":"

Phrase: "8806."

Phrase: "[Abstract/Free FullText"

Phrase: "] Saag KG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022718:KG [Geographic Area]
   861   C0439209:kg [Quantitative Concept]

Phrase: "Rubenstein LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "Chrischilles EA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.216: Nonsteroidal antiinflammatory drugs and cognitive decline in the elderly. 

Phrase: "Nonsteroidal antiinflammatory drugs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0003211:Nonsteroidal Anti-inflammatory Drugs [Pharmacologic Substance]
   988 E C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   901   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   827   C0013227:Drugs [Pharmacologic Substance]
   827   C1515999:Anti-inflammatory [Qualitative Concept]
   793 E C1254351:Drug [Pharmacologic Substance]
   755 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   755 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   727 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "and"

Phrase: "cognitive decline in the elderly."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]
Processing 00000000.tx.217: J Rheumatol 1995;22:21427.[ISI][Medline] Hanlon JT, Schmader KE, Landerman LR, et al. 

Phrase: "J Rheumatol 1995"

Phrase: ";22"

Phrase: ":"

Phrase: "21427."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hanlon JT,"

Phrase: "Schmader KE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022558:KE [Geographic Area]

Phrase: "Landerman LR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0023617:LR [Geographic Area]
   861   C2986899:LR [Idea or Concept]

Phrase: "et al."
Processing 00000000.tx.218: Relation of prescription nonsteroidal antiinflammatory drug use to cognitive function among community-dwelling elderly. 

Phrase: "Relation of prescription nonsteroidal antiinflammatory drug use"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0080103:Relation [Family Group]
   748   C0869014:relation [Social Behavior]

Phrase: "to cognitive function"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0392335:cognitive function [Mental Process]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1516691:Cognitive [Functional Concept]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "among community-dwelling elderly."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001792:Elderly [Population Group]
   827   C1999167:elderly [Population Group]
Processing 00000000.tx.219: Ann Epidemiol 1997;7:8794.[CrossRef][ISI][Medline] Jonker C, Comijs HC, Smit JH. 

Phrase: "Ann Epidemiol 1997"

Phrase: ";7"

Phrase: ":"

Phrase: "8794."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jonker C,"

Phrase: "Comijs HC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020268:HC [Hormone,Pharmacologic Substance,Steroid]
   861   C1413512:Hc [Gene or Genome]

Phrase: "Smit JH."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]
Processing 00000000.tx.220: Does aspirin or other NSAIDs reduce the risk of cognitive decline in elderly persons? 

Phrase: "Does"

Phrase: "aspirin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004057:Aspirin [Organic Chemical,Pharmacologic Substance]
   944 E C0699274:Ecotrin [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "other NSAIDs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0003211:Nonsteroidal Anti-inflammatory Drugs [Pharmacologic Substance]
   988 E C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   901   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   827   C0013227:Drugs [Pharmacologic Substance]
   827   C1515999:Anti-inflammatory [Qualitative Concept]
   793 E C1254351:Drug [Pharmacologic Substance]
   755 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   755 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   727 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "reduce"

Phrase: "the risk of cognitive decline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035647:Risk [Qualitative Concept]

Phrase: "in elderly persons?"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C0001792:Elderly person [Population Group]
   861   C0027361:Persons [Population Group]
   827 E C2347489:Person [Group]
   777 E C1519021:Personal [Organism Attribute]
Processing 00000000.tx.221: Results form a population-based study. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a population-based study."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1709599:Population Based Study [Research Activity]
   913   C0681876:Population Study [Research Activity]
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]
Processing 00000000.tx.222: Neurobiol Aging 2003;24:5838.[CrossRef][ISI][Medline] Hee Kang J, Grodstein F. 

Phrase: "Neurobiol"

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "2003"

Phrase: ";24"

Phrase: ":"

Phrase: "5838."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hee Kang J,"

Phrase: "Grodstein F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.223: Regular use of nonsteroidal anti-inflammatory drugs and cognitive function in aging women. 

Phrase: "Regular use of nonsteroidal anti-inflammatory drugs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1524063:Use of [Functional Concept]
   757   C0242510:drug use [Mental or Behavioral Dysfunction]
   748   C0042153:use [Functional Concept]
   748   C0457083:Use [Functional Concept]
   748   C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "cognitive function in aging women."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0392335:cognitive function [Mental Process]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1516691:Cognitive [Functional Concept]
   760   C1705273:Function [Intellectual Product]
Processing 00000000.tx.224: Neurology 2003;60:15917.[Abstract/Free FullText] Scharf S, Mander A, Ugoni A, et al. 

Phrase: "Neurology 2003"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";60"

Phrase: ":"

Phrase: "15917."

Phrase: "[Abstract/Free FullText"

Phrase: "] Scharf S,"

Phrase: "Mander A,"

Phrase: "Ugoni A,"

Phrase: "et al."
Processing 00000000.tx.225: A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimers disease. 

Phrase: "A double-blind, placebo-controlled trial of diclofenac/misoprostol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0008976:Trial [Research Activity]

Phrase: "in Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.226: Neurology 1999;53:197201.[Abstract/Free FullText] Aisen P, Schmeidler J, Pasinetti GM. 

Phrase: "Neurology 1999"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";53"

Phrase: ":"

Phrase: "197201."

Phrase: "[Abstract/Free FullText"

Phrase: "] Aisen P,"

Phrase: "Schmeidler J,"

Phrase: "Pasinetti GM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]
Processing 00000000.tx.227: Randomized pilot study of nimesulide treatment in Alzheimers disease. 

Phrase: "Randomized pilot study of nimesulide treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0031928:Pilot Study [Research Activity]
   783   C3161471:Treatment Study [Research Activity]
   753   C0473169:Pilot [Professional or Occupational Group]
   753   C0557651:Study [Manufactured Object]
   753   C1414316:PILOT [Gene or Genome]
   753   C2603343:Study [Research Activity]

Phrase: "in Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.228: Neurology 2002;58:10504.[Abstract/Free FullText] Aisen PS, Schafer KA, Grundman M, et al. 

Phrase: "Neurology 2002"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";58"

Phrase: ":"

Phrase: "10504."

Phrase: "[Abstract/Free FullText"

Phrase: "] Aisen PS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "Schafer KA,"

Phrase: "Grundman M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.229: Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. 

Phrase: "Effects of rofecoxib"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "naproxen"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027396:Naproxen [Organic Chemical,Pharmacologic Substance]
   944 E C0700017:Naprosyn [Organic Chemical,Pharmacologic Substance]

Phrase: "vs"

Phrase: "placebo on Alzheimer disease progression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0032042:placebo [Therapeutic or Preventive Procedure]
   760   C1696465:placebo [Biomedical or Dental Material]
   760   C1706408:PLACEBO [Research Activity]

Phrase: ":"

Phrase: "a randomized controlled trial."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C0282440:randomized controlled trial [Intellectual Product,Research Activity]
  1000   C1096777:Randomized Controlled Trial [Intellectual Product,Research Activity]
   827   C0008976:Trial [Research Activity]
   827   C0034656:randomized [Research Activity]
   827   C2587213:Controlled [Functional Concept]
   793 E C0243148:control [Qualitative Concept]
   793 E C1550141:Control [Substance]
   793 E C1882979:Control [Conceptual Entity]
   793 E C3274648:Control [Qualitative Concept]
Processing 00000000.tx.230: JAMA 2003;289:281926.[Abstract/Free FullText] Helmuth L. 

Phrase: "JAMA 2003"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1422839:JAMA [Gene or Genome]

Phrase: ";289"

Phrase: ":"

Phrase: "281926."

Phrase: "[Abstract/Free FullText"

Phrase: "] Helmuth L."
Processing 00000000.tx.231: NSAIDs for prevention? 

Phrase: "NSAIDs for prevention?"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   862   C0003211:Nonsteroidal Anti-inflammatory Drugs [Pharmacologic Substance]
   851 E C3536840:Non-steroidal Anti-inflammatory Drug [Pharmacologic Substance]
   806   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   760   C0013227:Drugs [Pharmacologic Substance]
   760   C1515999:Anti-inflammatory [Qualitative Concept]
   726 E C1254351:Drug [Pharmacologic Substance]
Processing 00000000.tx.232: Protecting the brain while killing pain? 

Phrase: "Protecting"

Phrase: "the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "while"

Phrase: "killing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:Killing [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: "pain?"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030193:Pain [Sign or Symptom]
  1000   C1962977:Pain NOS [Finding]
Processing 00000000.tx.233: Science 2002;297:12623.[Abstract/Free FullText] McGeer PL, Schulzer M, McGeer EG. 

Phrase: "Science 2002"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ";297"

Phrase: ":"

Phrase: "12623."

Phrase: "[Abstract/Free FullText"

Phrase: "] McGeer PL,"

Phrase: "Schulzer M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "McGeer EG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013715:EG [Geographic Area]
   861   C1705651:EG [Idea or Concept]
Processing 00000000.tx.234: Arthritis and anti-inflammatory agents as possible protective factors for Alzheimers disease. 

Phrase: "Arthritis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003864:Arthritis [Disease or Syndrome]
   907 E C0018099:Gout [Disease or Syndrome]

Phrase: "and"

Phrase: "anti-inflammatory agents as possible protective factors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C0003209:Anti-Inflammatory Agents [Pharmacologic Substance]
   774   C0033613:Protective Agents [Pharmacologic Substance]
   774   C0040616:anti-agents [Pharmacologic Substance]
   714   C0450442:Agent [Chemical Viewed Functionally]
   714   C1254351:Agent [Pharmacologic Substance]
   714   C1521826:Agent [Intellectual Product]

Phrase: "for Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.235: A review of 17 epidemiologic studies. 

Phrase: "A review of 17 epidemiologic studies."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0282443:Review [Intellectual Product]
   753   C1552617:Review [Idea or Concept]
Processing 00000000.tx.236: Neurology 1996;47:42532.[Abstract] DerSimonian R, Laird N. 

Phrase: "Neurology 1996"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";47"

Phrase: ":"

Phrase: "42532."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] DerSimonian R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Laird N."
Processing 00000000.tx.237: Meta-analysis in clinical trials. 

Phrase: "Meta-analysis in clinical trials."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0282458:Meta-Analysis [Intellectual Product]
   806   C0920317:Meta-Analysis [Research Activity]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1042496:Meta [Eukaryote]
   760   C1524024:analysis [Functional Concept]
Processing 00000000.tx.238: Control Clin Trials 1986;7:17788.[CrossRef][ISI][Medline] Egger M, Davey Smith G, Schneider M, et al. 

Phrase: "Control Clin Trials 1986"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0243148:control [Qualitative Concept]
   812   C1315013:CLIN [Intellectual Product]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]
   779   C0008976:Trial [Research Activity]

Phrase: ";7"

Phrase: ":"

Phrase: "17788."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Egger M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Davey Smith G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "Schneider M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.239: Bias in meta-analysis detected by a simple, graphical test. 

Phrase: "Bias in meta-analysis"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0242568:Bias [Idea or Concept]
   770   C1504315:Bias [Bird]
   737 E C1061346:Bia [Eukaryote]
   737 E C1704746:BIA [Diagnostic Procedure]

Phrase: "detected by a simple, graphical test."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0022885:Test [Laboratory Procedure]
   753   C0039593:Test [Functional Concept]
   753   C0205352:Simple [Qualitative Concept]
   753   C0392366:test [Intellectual Product]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.240: BMJ 1997;315:62934.[Abstract/Free FullText] Benedetti F, Vighetti S, Ricco C, et al. 

Phrase: "BMJ 1997"

Phrase: ";315"

Phrase: ":"

Phrase: "62934."

Phrase: "[Abstract/Free FullText"

Phrase: "] Benedetti F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Vighetti S,"

Phrase: "Ricco C,"

Phrase: "et al."
Processing 00000000.tx.241: Pain threshold and tolerance in Alzheimers disease. 

Phrase: "Pain threshold"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162703:Pain Threshold [Finding]
   861   C0030193:Pain [Sign or Symptom]
   861   C0449864:Threshold [Qualitative Concept]
   861   C1962977:Pain NOS [Finding]

Phrase: "and"

Phrase: "tolerance in Alzheimers disease."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0013220:Tolerance [Finding]
   770   C0020963:Tolerance [Pathologic Function]
   770   C0220929:tolerance [Mental Process]
   770   C0231197:Tolerance [Physiologic Function]
   770   C1704410:Tolerance [Qualitative Concept]
   715 E C0680282:toleration [Social Behavior]
Processing 00000000.tx.242: Pain 1999;80:37782.[CrossRef][ISI][Medline] Scherder E, Bouma A, Slaets J, et al. 

Phrase: "Pain 1999"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030193:Pain [Sign or Symptom]
   861   C1962977:Pain NOS [Finding]

Phrase: ";80"

Phrase: ":"

Phrase: "37782."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Scherder E,"

Phrase: "Bouma A,"

Phrase: "Slaets J,"

Phrase: "et al."
Processing 00000000.tx.243: Repeated pain assessment in Alzheimers disease. 

Phrase: "Repeated pain assessment in Alzheimers disease."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0030198:Pain Assessment [Diagnostic Procedure]
   753   C0030193:Pain [Sign or Symptom]
   753   C1261322:Assessment [Health Care Activity]
   753   C1516048:Assessment [Activity]
   753   C1962977:Pain NOS [Finding]
Processing 00000000.tx.244: Dement Geriatr Cogn Disord 2001;12:4007.[CrossRef][ISI][Medline] Martin BK, Meinert CL, Breitner JC, et al. 

Phrase: "Dement Geriatr Cogn Disord 2001"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0860630:dement [Mental or Behavioral Dysfunction]
   704 E C0011265:dementia [Mental or Behavioral Dysfunction]
   704 E C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: ";12"

Phrase: ":"

Phrase: "4007."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Martin BK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006100:BK [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C1537501:BK [Gene or Genome]

Phrase: "Meinert CL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "Breitner JC,"

Phrase: "et al."
Processing 00000000.tx.245: Double placebo design in a prevention trial for Alzheimers disease. 

Phrase: "Double placebo design in a prevention trial"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C3641234:Trial Design [Intellectual Product]
   748   C1707689:Design [Activity]
   748   C2983265:DESIGN [Intellectual Product]

Phrase: "for Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.246: Control Clin Trials 2002;23:939.[CrossRef][ISI][Medline] Etminan M, Gill S, Samii A. 

Phrase: "Control Clin Trials 2002"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0243148:control [Qualitative Concept]
   812   C1315013:CLIN [Intellectual Product]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]
   779   C0008976:Trial [Research Activity]

Phrase: ";23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ":"

Phrase: "939."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Etminan M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Gill S,"

Phrase: "Samii A."
Processing 00000000.tx.247: Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimers disease: systematic review and meta-analysis of observational studies. 

Phrase: "Effect of non-steroidal anti-inflammatory drugs"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   804   C0728866:effect of drugs [Functional Concept]
           Drug effect
   804   C1515999:Anti-inflammatory effect [Qualitative Concept]
   804   C1516019:Antiinflammatory Effect [Physiologic Function]
   757   C0728867:Drug effect [Pathologic Function]
   757   C1411996:drug effect [Biologic Function]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]
   722   C3536840:Non-steroidal Antiinflammatory Drug [Pharmacologic Substance]
   720 E C0003211:Non-steroidal anti-inflammatory drug [Pharmacologic Substance]

Phrase: "on risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "of Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "systematic review"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1955832:Review, Systematic [Intellectual Product]
   861   C0220922:systematic [Functional Concept]
   861   C0282443:Review [Intellectual Product]
   861   C1552617:Review [Idea or Concept]

Phrase: "and"

Phrase: "meta-analysis of observational studies."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0282458:Meta-Analysis [Intellectual Product]
   806   C0920317:Meta-Analysis [Research Activity]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1042496:Meta [Eukaryote]
   760   C1524024:analysis [Functional Concept]
Processing 00000000.tx.248: BMJ 2003;327:12831.[Abstract/Free FullText] Robertson M. 

Phrase: "BMJ 2003"

Phrase: ";327"

Phrase: ":"

Phrase: "12831."

Phrase: "[Abstract/Free FullText"

Phrase: "] Robertson M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.249: Effect of NSAIDs on risk of Alzheimers disease: confounding factors were not discussed. 

Phrase: "Effect of NSAIDs"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   844   C0728866:effect of drugs [Functional Concept]
           Drug effect
   797   C1515999:Anti-inflammatory effect [Qualitative Concept]
   797   C1516019:Antiinflammatory Effect [Physiologic Function]
   781   C0728867:Drug effect [Pathologic Function]
   781   C1411996:drug effect [Biologic Function]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "of Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "confounding factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "discussed."
Processing 00000000.tx.250: (Letter). 

Phrase: "(Letter"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1096774:Letter [Intellectual Product]
  1000   C2360551:Letter [Clinical Attribute]
   944 E C0079691:Levothyroxine Sodium [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C0282413:letters [Intellectual Product]
   916 E C0728762:Synthroid [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.251: BMJ 2003;327:751.[Free FullText] Haan M, Shemanski L, Jagust WJ, et al. 

Phrase: "BMJ 2003"

Phrase: ";327"

Phrase: ":"

Phrase: "751."

Phrase: "[Free FullText"

Phrase: "] Haan M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Shemanski L,"

Phrase: "Jagust WJ,"

Phrase: "et al."
Processing 00000000.tx.252: Predictors of cognitive change in the Cardiovascular Health Study: the role of cardiovascular and genetic risk factors. 

Phrase: "Predictors of cognitive change"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C2698872:Predictor [Idea or Concept]

Phrase: "in the Cardiovascular Health Study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]

Phrase: ":"

Phrase: "the role of cardiovascular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "genetic risk factors."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0814299:genetic risk factors [Qualitative Concept]
   901   C0035648:risk factors [Quantitative Concept]
   901   C1553898:risk factors [Idea or Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
   734   C1517512:Genetic Risk [Quantitative Concept]
Processing 00000000.tx.253: JAMA 1999;282:406.[Abstract/Free FullText] Ince PG. 

Phrase: "JAMA 1999"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1422839:JAMA [Gene or Genome]

Phrase: ";282"

Phrase: ":"

Phrase: "406."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ince PG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1266240:PG [Laboratory Procedure]
Processing 00000000.tx.254: Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. 

Phrase: "Pathological correlates of late-onset dementia"

Phrase: "in a multicentre,"

Phrase: "community-based population in England"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0032659:Population [Quantitative Concept]
   760   C1257890:Population [Population Group]

Phrase: "and"

Phrase: "Wales."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043015:Wales [Geographic Area]
  1000   C1551837:Wales [Population Group]
Processing 00000000.tx.255: Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). 

Phrase: "Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS)."
Meta Candidates (Total=30; Excluded=1; Pruned=0; Remaining=29)
   753   C0079816:Medical Research [Research Activity]
   753   C0392335:cognitive function [Mental Process]
   753   C1556038:Medical Research [Professional or Occupational Group]
   751   C0681814:research study [Research Activity]
   751   C1556037:Research Study [Professional or Occupational Group]
   736   C0001811:Ageing [Organism Function]
   736   C0031843:function [Physiologic Function]
   736   C0035168:research [Research Activity]
   736   C0205476:Medical [Functional Concept]
   736   C0242481:Research [Research Activity]
   736   C0441833:Group [Idea or Concept]
   736   C0542341:Function [Functional Concept]
   736   C0557651:Study [Manufactured Object]
   736   C0687744:group [Population Group]
   736   C0700205:FUNCTION [Classification]
   736   C0876934:Neuropathology [Biomedical Occupation or Discipline]
   736   C1257890:Group [Population Group]
   736   C1516691:Cognitive [Functional Concept]
   736   C1540677:neuropathology [Pathologic Function]
   736   C1551807:Council [Population Group]
   736   C1552516:Group [Health Care Related Organization]
   736   C1555824:Neuropathology [Intellectual Product]
   736   C1705273:Function [Intellectual Product]
   736   C1705428:Group [Conceptual Entity]
   736   C1705429:Group [Population Group]
   736   C2603343:Study [Research Activity]
   734   C0027362:Age Group [Age Group]
   734   C2348001:Age Group [Population Group]
   715   C0598132:functional group [Chemical Viewed Functionally]
   703 E C0001779:Age [Organism Attribute]
Processing 00000000.tx.256: Lancet 2001;357:16975.[CrossRef][ISI][Medline] Kalaria RN. 

Phrase: "Lancet 2001"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: ";357"

Phrase: ":"

Phrase: "16975."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kalaria RN."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540639:RN [Gene or Genome]
Processing 00000000.tx.257: The role of cerebral ischemia in Alzheimers disease. 

Phrase: "The role of cerebral ischemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.258: Neurobiol Aging 2000;21:32130.[CrossRef][ISI][Medline] Weggen S, Eriksen JL, Das P, et al. 

Phrase: "Neurobiol"

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "2000"

Phrase: ";21"

Phrase: ":"

Phrase: "32130."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Weggen S,"

Phrase: "Eriksen JL,"

Phrase: "Das P,"

Phrase: "et al."
Processing 00000000.tx.259: A subset of NSAIDs lower amyloidogenic A42 independently of cyclooxygenase activity. 

Phrase: "A subset of NSAIDs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1515021:Subset [Classification]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "amyloidogenic A42 independently of cyclooxygenase activity."
Processing 00000000.tx.260: Nature 2001;414:21216.[CrossRef][ISI][Medline] This Article Abstract FREE Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to citation manager Search for citing articles in: ISI Web of Science (3) Disclaimer Request Permissions Google Scholar Articles by de Craen, A. 

Phrase: "Nature 2001"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ";414"

Phrase: ":"

Phrase: "21216."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "This Article Abstract FREE Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1527021:Text [Intellectual Product]
   804   C1554111:Text [Idea or Concept]
   804   C1705606:Text [Intellectual Product]
   804   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0557854:Services [Occupational Activity]
   966 E C2825316:Service [Manufactured Object]
   966 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in ISI Web"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282111:Web [Manufactured Object]

Phrase: "of Science Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0162443:Journal [Intellectual Product,Manufactured Object]
   748   C0205314:New [Temporal Concept]
   714   C0033213:Issue [Finding]
   714   C1706387:Issue [Intellectual Product]

Phrase: "Add to My Personal Archive Download"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0003738:archive [Manufactured Object]
   753   C0024552:MY [Geographic Area]
   753   C1519021:Personal [Organism Attribute]
   753   C1554162:Archive [Idea or Concept]
   753   C1883712:Add [Functional Concept]

Phrase: "to citation manager Search"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1552603:search [Intellectual Product]
   827   C1706202:Search [Activity]

Phrase: "for citing articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1706852:Article [Intellectual Product]

Phrase: "in"

Phrase: ":"

Phrase: "ISI Web of Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0282111:Web [Manufactured Object]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "Disclaimer Request Permissions Google Scholar Articles by de Craen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1706852:Article [Intellectual Product]

Phrase: "A."
Processing 00000000.tx.261: J. 

Phrase: "J."
Processing 00000000.tx.262: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.263: Articles by Westendorp, R. 

Phrase: "Articles by Westendorp,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.264: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.265: J. 

Phrase: "J."
Processing 00000000.tx.266: PubMed PubMed Citation Articles by de Craen, A. 

Phrase: "PubMed PubMed Citation Articles by de Craen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1706852:Article [Intellectual Product]

Phrase: "A."
Processing 00000000.tx.267: J. 

Phrase: "J."
Processing 00000000.tx.268: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.269: Articles by Westendorp, R. 

Phrase: "Articles by Westendorp,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.270: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.271: J. 

Phrase: "J."
Processing 00000000.tx.272: Online ISSN 1476-6256 - Print ISSN 0002-9262 Copyright  2006 Johns Hopkins Bloomberg School of Public Health Oxford Journals Oxford University Press Site Map Privacy Policy Frequently Asked Questions Other Oxford University Press sites: Oxford University Press American National Biography Booksellers' Information Service Children's Fiction and Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights and Permissions Science School Books Social Sciences Very Short Introductions World's Classics

Phrase: "Online ISSN 1476-6256 - Print ISSN 0002-9262 Copyright  2006 Johns Hopkins Bloomberg School"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   786   C0036375:School [Manufactured Object,Organization]

Phrase: "of Public Health Oxford Journals Oxford University Press Site Map Privacy Policy Frequently"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   883   C0680811:public health policy [Governmental or Regulatory Activity,Intellectual Product]
   881   C0034033:Public Policy [Governmental or Regulatory Activity]
   871   C0018735:Health Policy [Regulation or Law]
   799   C2735290:Privacy policy [Intellectual Product]
   787   C0242456:Policy [Intellectual Product]

Phrase: "Asked"

Phrase: "Questions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "Other Oxford University Press sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205145:Sites [Spatial Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: ":"

Phrase: "Oxford University Press American National Biography Booksellers' Information Service Children's Fiction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0887933:fiction [Intellectual Product]

Phrase: "and"

Phrase: "Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary"

Phrase: "of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   852   C0947619:Finger.right [Body Part, Organ, or Organ Component]
   782   C0035621:Rights [Qualitative Concept]
   782   C0205090:Right [Spatial Concept]

Phrase: "and"

Phrase: "Permissions Science School Books Social Sciences Very Short Introductions World's Classics"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   788   C0439658:classics [Qualitative Concept]
   755 E C0439858:Classic [Qualitative Concept]

